activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1512980	CHEMBL831128	Inhibition of human cyclin G associated kinase at 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	135.0	CHEMBL4355	Homo sapiens	IC50	nM	135.0
	1512980	CHEMBL831128	Inhibition of human cyclin G associated kinase at 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	135.0	CHEMBL4355	Homo sapiens	IC50	nM	135.0
Not Active	1650072	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4355	Homo sapiens	Kd		
	1650073	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	1.5	CHEMBL4355	Homo sapiens	Kd	uM	0.0015
Not Active	1650074	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4355	Homo sapiens	Kd		
	1650075	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	120.0	CHEMBL4355	Homo sapiens	Kd	uM	0.12
Not Active	1650076	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4355	Homo sapiens	Kd		
	1650077	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1300.0	CHEMBL4355	Homo sapiens	Kd	uM	1.3
Not Active	1650078	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Active	1650079	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4355	Homo sapiens	Kd		
	1650080	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1100.0	CHEMBL4355	Homo sapiens	Kd	uM	1.1
	1651500	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	68.0	CHEMBL4355	Homo sapiens	Kd	uM	0.068
	1651501	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	650.0	CHEMBL4355	Homo sapiens	Kd	uM	0.65
	1651502	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	39.0	CHEMBL4355	Homo sapiens	Kd	uM	0.039
Not Active	1651503	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Active	1651504	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4355	Homo sapiens	Kd		
	1651505	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	38.0	CHEMBL4355	Homo sapiens	Kd	uM	0.038
	1651506	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	3600.0	CHEMBL4355	Homo sapiens	Kd	uM	3.6
	1651507	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	7.0	CHEMBL4355	Homo sapiens	Kd	uM	0.007
	1651508	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	40.0	CHEMBL4355	Homo sapiens	Kd	uM	0.04
	1651509	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	330.0	CHEMBL4355	Homo sapiens	Kd	uM	0.33
	1651510	CHEMBL860789	Average Binding Constant for GAK; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	44.0	CHEMBL4355	Homo sapiens	Kd	uM	0.044
	1689328	CHEMBL862341	Inhibition of GAK at 10 uM	B	Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1		CHEMBL203567	=	Kd	nM	590.0	CHEMBL4355	Homo sapiens	Kd	uM	0.59
	2206762	CHEMBL974029	Inhibition of Gak	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	40.0	CHEMBL4355	Homo sapiens	Kd	nM	40.0
	2206805	CHEMBL974029	Inhibition of Gak	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	120.0	CHEMBL4355	Homo sapiens	Kd	nM	120.0
	2393729	CHEMBL1004484	Binding affinity to human recombinant GAK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	<	Tm	degrees C	2.0	CHEMBL4355	Homo sapiens	Tm	degrees C	2.0
	2393730	CHEMBL1004484	Binding affinity to human recombinant GAK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	<	Tm	degrees C	2.0	CHEMBL4355	Homo sapiens	Tm	degrees C	2.0
	2393731	CHEMBL1004484	Binding affinity to human recombinant GAK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCC[C@@H](O)[C@@H](C)CC/C=C/2		CHEMBL454394	<	Tm	degrees C	2.0	CHEMBL4355	Homo sapiens	Tm	degrees C	2.0
	2393732	CHEMBL1004484	Binding affinity to human recombinant GAK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)CCCC(=O)[C@@H](C)CC/C=C/2		CHEMBL453389	<	Tm	degrees C	2.0	CHEMBL4355	Homo sapiens	Tm	degrees C	2.0
	2393733	CHEMBL1004484	Binding affinity to human recombinant GAK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	COc1cc(O)c2c(c1)/C=C/CC[C@H](C)C(=O)CCC[C@H](C)OC2=O		CHEMBL510836	<	Tm	degrees C	2.0	CHEMBL4355	Homo sapiens	Tm	degrees C	2.0
	2393734	CHEMBL1004484	Binding affinity to human recombinant GAK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)CCC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL454173	=	Tm	degrees C	2.4	CHEMBL4355	Homo sapiens	Tm	degrees C	2.4
	2393735	CHEMBL1004484	Binding affinity to human recombinant GAK expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry	B	C[C@H]1CCCC(=O)[C@@H](C)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL453375	=	Tm	degrees C	2.9	CHEMBL4355	Homo sapiens	Tm	degrees C	2.9
	2470235	CHEMBL984521	Inhibition of GAK at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4355	Homo sapiens	INH	%	10.0
	2476591	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	0.1	CHEMBL4355	Homo sapiens	Activity	%	0.1
	2476794	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582	=	Activity	%	3.0	CHEMBL4355	Homo sapiens	Activity	%	3.0
Not Evaluated	2478633	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4355	Homo sapiens	Activity		
	2478836	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	0.1	CHEMBL4355	Homo sapiens	Activity	%	0.1
	2479562	CHEMBL988955	Binding affinity to human GAK	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Kd	nM	367.0	CHEMBL4355	Homo sapiens	Kd	nM	367.0
	2479691	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	0.2	CHEMBL4355	Homo sapiens	Activity	%	0.2
	2480690	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	2.7	CHEMBL4355	Homo sapiens	Activity	%	2.7
	2577312	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	4.5	CHEMBL4355	Homo sapiens	Activity	%	4.5
	2577515	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	0.5	CHEMBL4355	Homo sapiens	Activity	%	0.5
	2593517	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	16.2	CHEMBL4355	Homo sapiens	Activity	%	16.2
	2593720	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.2	CHEMBL4355	Homo sapiens	Activity	%	0.2
	2593986	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.3	CHEMBL4355	Homo sapiens	Activity	%	0.3
Not Evaluated	2594929	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4355	Homo sapiens	Activity		
Not Evaluated	2595132	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4355	Homo sapiens	Activity		
Not Evaluated	2595198	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4355	Homo sapiens	Activity		
Active	2596329	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4355	Homo sapiens	Activity		
	2597598	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	1.9	CHEMBL4355	Homo sapiens	Activity	%	1.9
Active	2597801	CHEMBL993455	Binding affinity to human GAK at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4355	Homo sapiens	Activity		
	2896869	CHEMBL1062777	Binding constant for GAK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896870	CHEMBL1062777	Binding constant for GAK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896871	CHEMBL1062777	Binding constant for GAK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1300.0	CHEMBL4355	Homo sapiens	Kd	nM	1300.0
	2896872	CHEMBL1062777	Binding constant for GAK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896873	CHEMBL1062777	Binding constant for GAK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896874	CHEMBL1062777	Binding constant for GAK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1800.0	CHEMBL4355	Homo sapiens	Kd	nM	1800.0
	2896875	CHEMBL1062777	Binding constant for GAK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	490.0	CHEMBL4355	Homo sapiens	Kd	nM	490.0
	2896876	CHEMBL1062777	Binding constant for GAK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896877	CHEMBL1062777	Binding constant for GAK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	100.0	CHEMBL4355	Homo sapiens	Kd	nM	100.0
	2896878	CHEMBL1062777	Binding constant for GAK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896879	CHEMBL1062777	Binding constant for GAK kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896880	CHEMBL1062777	Binding constant for GAK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2.6	CHEMBL4355	Homo sapiens	Kd	nM	2.6
	2896881	CHEMBL1062777	Binding constant for GAK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	6.4	CHEMBL4355	Homo sapiens	Kd	nM	6.4
	2896882	CHEMBL1062777	Binding constant for GAK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3.1	CHEMBL4355	Homo sapiens	Kd	nM	3.1
	2896883	CHEMBL1062777	Binding constant for GAK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	370.0	CHEMBL4355	Homo sapiens	Kd	nM	370.0
	2896884	CHEMBL1062777	Binding constant for GAK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	13.0	CHEMBL4355	Homo sapiens	Kd	nM	13.0
	2896885	CHEMBL1062777	Binding constant for GAK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896886	CHEMBL1062777	Binding constant for GAK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	200.0	CHEMBL4355	Homo sapiens	Kd	nM	200.0
	2896887	CHEMBL1062777	Binding constant for GAK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	1000.0	CHEMBL4355	Homo sapiens	Kd	nM	1000.0
	2896888	CHEMBL1062777	Binding constant for GAK kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	2400.0	CHEMBL4355	Homo sapiens	Kd	nM	2400.0
	2896889	CHEMBL1062777	Binding constant for GAK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896890	CHEMBL1062777	Binding constant for GAK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1100.0	CHEMBL4355	Homo sapiens	Kd	nM	1100.0
	2896891	CHEMBL1062777	Binding constant for GAK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896892	CHEMBL1062777	Binding constant for GAK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896893	CHEMBL1062777	Binding constant for GAK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896894	CHEMBL1062777	Binding constant for GAK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	380.0	CHEMBL4355	Homo sapiens	Kd	nM	380.0
	2896895	CHEMBL1062777	Binding constant for GAK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896896	CHEMBL1062777	Binding constant for GAK kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896897	CHEMBL1062777	Binding constant for GAK kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	53.0	CHEMBL4355	Homo sapiens	Kd	nM	53.0
	2896898	CHEMBL1062777	Binding constant for GAK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	19.0	CHEMBL4355	Homo sapiens	Kd	nM	19.0
	2896899	CHEMBL1062777	Binding constant for GAK kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896900	CHEMBL1062777	Binding constant for GAK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896901	CHEMBL1062777	Binding constant for GAK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	17.0	CHEMBL4355	Homo sapiens	Kd	nM	17.0
	2896902	CHEMBL1062777	Binding constant for GAK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	44.0	CHEMBL4355	Homo sapiens	Kd	nM	44.0
	2896903	CHEMBL1062777	Binding constant for GAK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	20.0	CHEMBL4355	Homo sapiens	Kd	nM	20.0
	2896904	CHEMBL1062777	Binding constant for GAK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	3200.0	CHEMBL4355	Homo sapiens	Kd	nM	3200.0
	2896905	CHEMBL1062777	Binding constant for GAK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	2896906	CHEMBL1062777	Binding constant for GAK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	86.0	CHEMBL4355	Homo sapiens	Kd	nM	86.0
Antagonist	2902194	CHEMBL1062807	Percentage GAK activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	6.0	CHEMBL4355	Homo sapiens	Activity	%	6.0
Antagonist	2902195	CHEMBL1062807	Percentage GAK activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	6.0	CHEMBL4355	Homo sapiens	Activity	%	6.0
	2902196	CHEMBL1062807	Percentage GAK activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	83.0	CHEMBL4355	Homo sapiens	Activity	%	83.0
	2902197	CHEMBL1062807	Percentage GAK activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	90.0	CHEMBL4355	Homo sapiens	Activity	%	90.0
	2902198	CHEMBL1062013	Percentage GAK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	94.0	CHEMBL4355	Homo sapiens	Activity	%	94.0
Antagonist	2902199	CHEMBL1062013	Percentage GAK activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	25.0	CHEMBL4355	Homo sapiens	Activity	%	25.0
Antagonist	2902200	CHEMBL1062013	Percentage GAK activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
Antagonist	2902201	CHEMBL1062013	Percentage GAK activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	32.0	CHEMBL4355	Homo sapiens	Activity	%	32.0
	2902202	CHEMBL1062013	Percentage GAK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	57.0	CHEMBL4355	Homo sapiens	Activity	%	57.0
Antagonist	2902203	CHEMBL1062013	Percentage GAK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	20.0	CHEMBL4355	Homo sapiens	Activity	%	20.0
Antagonist	2902204	CHEMBL1062013	Percentage GAK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	43.0	CHEMBL4355	Homo sapiens	Activity	%	43.0
	2902205	CHEMBL1062013	Percentage GAK activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	79.0	CHEMBL4355	Homo sapiens	Activity	%	79.0
Antagonist	2902206	CHEMBL1062013	Percentage GAK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	12.0	CHEMBL4355	Homo sapiens	Activity	%	12.0
	2921322	CHEMBL1053743	Inhibition of GAK assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	92.0	CHEMBL4355	Homo sapiens	Activity	%	92.0
	2928480	CHEMBL1049978	Binding affinity to GAK assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	49.0	CHEMBL4355	Homo sapiens	Activity	%	49.0
	3331957	CHEMBL1169247	Inhibition of GAK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	3333372	CHEMBL1169247	Inhibition of GAK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	3334777	CHEMBL1169247	Inhibition of GAK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	3336197	CHEMBL1169247	Inhibition of GAK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	3337543	CHEMBL1169247	Inhibition of GAK at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	=	Inhibition	%	66.5	CHEMBL4355	Homo sapiens	INH	%	66.5
	3337793	CHEMBL1169247	Inhibition of GAK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	3339127	CHEMBL1169247	Inhibition of GAK at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	3340429	CHEMBL1169247	Inhibition of GAK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	3340725	CHEMBL1169247	Inhibition of GAK at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	3342141	CHEMBL1169247	Inhibition of GAK at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	3358593	CHEMBL1174438	Inhibition of GAK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	7.4	CHEMBL4355	Homo sapiens	INH	%	7.4
	3359035	CHEMBL1174438	Inhibition of GAK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	2.0	CHEMBL4355	Homo sapiens	INH	%	2.0
	3445132	CHEMBL1244854	Binding affinity to GAK	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	7.3	CHEMBL4355	Homo sapiens	Kd	nM	7.3
Not Active	3446230	CHEMBL1244370	Inhibition of GAK	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441		IC50			CHEMBL4355	Homo sapiens	IC50		
	3448443	CHEMBL1244854	Binding affinity to GAK	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	3448940	CHEMBL1244854	Binding affinity to GAK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	380.0	CHEMBL4355	Homo sapiens	Kd	nM	380.0
	3449203	CHEMBL1244854	Binding affinity to GAK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	20.0	CHEMBL4355	Homo sapiens	Kd	nM	20.0
	3449204	CHEMBL1244854	Binding affinity to GAK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	430.0	CHEMBL4355	Homo sapiens	Kd	nM	430.0
	3449676	CHEMBL1244854	Binding affinity to GAK	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
	3450086	CHEMBL1244854	Binding affinity to GAK	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	uM	10.0
Not Active	3499130	CHEMBL1259874	Inhibition of GAK at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL4355	Homo sapiens	INH		
	5126370	CHEMBL1646106	Inhibition at GAK at 10 uM relative to control	B	CCNc1nc2sc(-c3cccc([C@H](C)NC(C)=O)c3)nc2c2c1ncn2C		CHEMBL1642546	=	Inhibition	%	10.0	CHEMBL4355	Homo sapiens	INH	%	10.0
	5223290	CHEMBL1679282	Binding affinity to GAK at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2		CHEMBL1672987	>	Inhibition	%	90.0	CHEMBL4355	Homo sapiens	INH	%	90.0
	5223308	CHEMBL1679298	Binding affinity to GAK by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	=	Kd	nM	450.0	CHEMBL4355	Homo sapiens	Kd	nM	450.0
	6167601	CHEMBL1769244	Binding affinity to human GAK isoleucine residue assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	18.0	CHEMBL4355	Homo sapiens	Activity	%	18.0
	6167624	CHEMBL1768484	Binding affinity to human GAK isoleucine residue assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	5.1	CHEMBL4355	Homo sapiens	Activity	%	5.1
	6172870	CHEMBL1769110	Inhibition of GAK at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	>	Inhibition	%	85.0	CHEMBL4355	Homo sapiens	INH	%	85.0
	6172882	CHEMBL1769122	Inhibition of GAK	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21		CHEMBL1090089	>	Kd	nM	1000.0	CHEMBL4355	Homo sapiens	Kd	nM	1000.0
	6172934	CHEMBL1769110	Inhibition of GAK at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	>	Inhibition	%	85.0	CHEMBL4355	Homo sapiens	INH	%	85.0
	6172946	CHEMBL1769122	Inhibition of GAK	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	=	Kd	nM	680.0	CHEMBL4355	Homo sapiens	Kd	nM	680.0
	6208306	CHEMBL1781149	Inhibition of GAK at 10 uM	B	C[C@H](CS(C)(=O)=O)Nc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL1232769	=	Inhibition	%	87.0	CHEMBL4355	Homo sapiens	INH	%	87.0
	6339893	CHEMBL1826191	Activity of GAK kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	56.0	CHEMBL4355	Homo sapiens	Activity	%	56.0
	7567410	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	1700.0	CHEMBL4355	Homo sapiens	Kd	nM	1700.0
	7567898	CHEMBL1908709	Binding constant for GAK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	250.0	CHEMBL4355	Homo sapiens	Kd	nM	250.0
	7568366	CHEMBL1908709	Binding constant for GAK kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	8.2	CHEMBL4355	Homo sapiens	Kd	nM	8.2
	7568798	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	44.0	CHEMBL4355	Homo sapiens	Kd	nM	44.0
	7569383	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7569401	CHEMBL1908709	Binding constant for GAK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7569873	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	1000.0	CHEMBL4355	Homo sapiens	Kd	nM	1000.0
	7570336	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	1300.0	CHEMBL4355	Homo sapiens	Kd	nM	1300.0
	7570763	CHEMBL1908709	Binding constant for GAK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	20.0	CHEMBL4355	Homo sapiens	Kd	nM	20.0
	7571374	CHEMBL1908709	Binding constant for GAK kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7571850	CHEMBL1908709	Binding constant for GAK kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	99.0	CHEMBL4355	Homo sapiens	Kd	nM	99.0
	7572313	CHEMBL1908709	Binding constant for GAK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7572729	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	5.3	CHEMBL4355	Homo sapiens	Kd	nM	5.3
	7572898	CHEMBL1908709	Binding constant for GAK kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	180.0	CHEMBL4355	Homo sapiens	Kd	nM	180.0
	7573355	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2.6	CHEMBL4355	Homo sapiens	Kd	nM	2.6
	7573831	CHEMBL1908709	Binding constant for GAK kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	870.0	CHEMBL4355	Homo sapiens	Kd	nM	870.0
	7574300	CHEMBL1908709	Binding constant for GAK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	380.0	CHEMBL4355	Homo sapiens	Kd	nM	380.0
	7574708	CHEMBL1908709	Binding constant for GAK kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	1400.0	CHEMBL4355	Homo sapiens	Kd	nM	1400.0
	7574876	CHEMBL1908709	Binding constant for GAK kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7575337	CHEMBL1908709	Binding constant for GAK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3.1	CHEMBL4355	Homo sapiens	Kd	nM	3.1
	7575808	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	1500.0	CHEMBL4355	Homo sapiens	Kd	nM	1500.0
	7576273	CHEMBL1908709	Binding constant for GAK kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7576850	CHEMBL1908709	Binding constant for GAK kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	79.0	CHEMBL4355	Homo sapiens	Kd	nM	79.0
	7577309	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7577787	CHEMBL1908709	Binding constant for GAK kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	260.0	CHEMBL4355	Homo sapiens	Kd	nM	260.0
	7578220	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1.1	CHEMBL4355	Homo sapiens	Kd	nM	1.1
	7578858	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	180.0	CHEMBL4355	Homo sapiens	Kd	nM	180.0
	7579232	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7579682	CHEMBL1908709	Binding constant for GAK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	370.0	CHEMBL4355	Homo sapiens	Kd	nM	370.0
	7580183	CHEMBL1908709	Binding constant for GAK kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	320.0	CHEMBL4355	Homo sapiens	Kd	nM	320.0
	7580586	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	86.0	CHEMBL4355	Homo sapiens	Kd	nM	86.0
	7581216	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7581601	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7582046	CHEMBL1908709	Binding constant for GAK kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7582075	CHEMBL1908709	Binding constant for GAK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7582539	CHEMBL1908709	Binding constant for GAK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7582939	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	3200.0	CHEMBL4355	Homo sapiens	Kd	nM	3200.0
	7583562	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	2300.0	CHEMBL4355	Homo sapiens	Kd	nM	2300.0
	7583959	CHEMBL1908709	Binding constant for GAK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1800.0	CHEMBL4355	Homo sapiens	Kd	nM	1800.0
	7584433	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7584895	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	250.0	CHEMBL4355	Homo sapiens	Kd	nM	250.0
	7585299	CHEMBL1908709	Binding constant for GAK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7586304	CHEMBL1908709	Binding constant for GAK kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	2700.0	CHEMBL4355	Homo sapiens	Kd	nM	2700.0
	7586775	CHEMBL1908709	Binding constant for GAK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1100.0	CHEMBL4355	Homo sapiens	Kd	nM	1100.0
	7587229	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7587411	CHEMBL1908709	Binding constant for GAK kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7587830	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7588283	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	13.0	CHEMBL4355	Homo sapiens	Kd	nM	13.0
	7588754	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7589205	CHEMBL1908709	Binding constant for GAK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	19.0	CHEMBL4355	Homo sapiens	Kd	nM	19.0
	7589376	CHEMBL1908709	Binding constant for GAK kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	2700.0	CHEMBL4355	Homo sapiens	Kd	nM	2700.0
	7589800	CHEMBL1908709	Binding constant for GAK kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	7.3	CHEMBL4355	Homo sapiens	Kd	nM	7.3
	7590267	CHEMBL1908709	Binding constant for GAK kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	270.0	CHEMBL4355	Homo sapiens	Kd	nM	270.0
	7590741	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	3700.0	CHEMBL4355	Homo sapiens	Kd	nM	3700.0
	7591192	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7591349	CHEMBL1908709	Binding constant for GAK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7591771	CHEMBL1908709	Binding constant for GAK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	490.0	CHEMBL4355	Homo sapiens	Kd	nM	490.0
	7592243	CHEMBL1908709	Binding constant for GAK kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7592716	CHEMBL1908709	Binding constant for GAK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7593316	CHEMBL1908709	Binding constant for GAK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1300.0	CHEMBL4355	Homo sapiens	Kd	nM	1300.0
	7593751	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7594223	CHEMBL1908709	Binding constant for GAK kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7594706	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1.3	CHEMBL4355	Homo sapiens	Kd	nM	1.3
	7595284	CHEMBL1908709	Binding constant for GAK kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7595728	CHEMBL1908709	Binding constant for GAK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	100.0	CHEMBL4355	Homo sapiens	Kd	nM	100.0
	7596202	CHEMBL1908709	Binding constant for GAK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7596231	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7596678	CHEMBL1908709	Binding constant for GAK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7597256	CHEMBL1908709	Binding constant for GAK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7597709	CHEMBL1908709	Binding constant for GAK kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	7598210	CHEMBL1908709	Binding constant for GAK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	200.0	CHEMBL4355	Homo sapiens	Kd	nM	200.0
	7598652	CHEMBL1908709	Binding constant for GAK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	17.0	CHEMBL4355	Homo sapiens	Kd	nM	17.0
	7997659	CHEMBL1944391	Inhibition of GAK	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	98.0	CHEMBL4355	Homo sapiens	INH	%	98.0
	8009706	CHEMBL1941381	Inhibition of GAK at 1 uM	B	NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938642	>	Inhibition	%	90.0	CHEMBL4355	Homo sapiens	INH	%	90.0
	8009707	CHEMBL1941381	Inhibition of GAK at 1 uM	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCOCC4)c3s2)cc1		CHEMBL1938659	=	Inhibition	%	98.0	CHEMBL4355	Homo sapiens	INH	%	98.0
	8012908	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945557	=	Delta Tm	degrees C	0.9	CHEMBL4355	Homo sapiens	deltaTm	degrees C	0.9
	8012933	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCN(C(=O)OC(C)(C)C)CC1)NC2=O		CHEMBL1945558	=	Delta Tm	degrees C	-0.2	CHEMBL4355	Homo sapiens	deltaTm	degrees C	-0.2
	8012957	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	Delta Tm	degrees C	1.4	CHEMBL4355	Homo sapiens	deltaTm	degrees C	1.4
	8012981	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	N#CC1c2c([nH]c3c(Cl)c(Cl)ccc23)C(=O)NC12CCCCC2		CHEMBL1945560	=	Delta Tm	degrees C	2.8	CHEMBL4355	Homo sapiens	deltaTm	degrees C	2.8
	8013005	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(CN)C(C)(C)NC2=O		CHEMBL1945561	=	Delta Tm	degrees C	0.7	CHEMBL4355	Homo sapiens	deltaTm	degrees C	0.7
	8013030	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC(=O)NCC1c2c(n(C)c3c(Cl)c(Cl)ccc23)C(=O)NC1(C)C		CHEMBL1945562	=	Delta Tm	degrees C	0.5	CHEMBL4355	Homo sapiens	deltaTm	degrees C	0.5
	8027509	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc[nH]c(=O)c21		CHEMBL474872	=	Delta Tm	degrees C	3.3	CHEMBL4355	Homo sapiens	deltaTm	degrees C	3.3
	8027534	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc(N)[nH]c(=O)c21		CHEMBL1945336	=	Delta Tm	degrees C	4.3	CHEMBL4355	Homo sapiens	deltaTm	degrees C	4.3
	8027559	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C(C)(C)NC2=O		CHEMBL1945337	=	Delta Tm	degrees C	2.8	CHEMBL4355	Homo sapiens	deltaTm	degrees C	2.8
	8027584	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC1(C)NC(=O)c2[nH]c3c(Cl)c(Cl)ccc3c2C1C#N		CHEMBL1945338	=	Delta Tm	degrees C	2.5	CHEMBL4355	Homo sapiens	deltaTm	degrees C	2.5
	8027609	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCC1(CC)NC(=O)c2c(c3ccc(Cl)c(Cl)c3n2C)C1C#N		CHEMBL1945339	=	Delta Tm	degrees C	1.2	CHEMBL4355	Homo sapiens	deltaTm	degrees C	1.2
	8027634	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccccc31)C(C#N)C(C)(C)NC2=O		CHEMBL1945340	=	Delta Tm	degrees C	0.0	CHEMBL4355	Homo sapiens	deltaTm	degrees C	0.0
	8027656	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCCCC1)NC2=O		CHEMBL1945341	=	Delta Tm	degrees C	0.9	CHEMBL4355	Homo sapiens	deltaTm	degrees C	0.9
	8027670	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCCC1)NC2=O		CHEMBL1945554	=	Delta Tm	degrees C	1.2	CHEMBL4355	Homo sapiens	deltaTm	degrees C	1.2
	8027695	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCOCC1)NC2=O		CHEMBL1945335	=	Delta Tm	degrees C	1.3	CHEMBL4355	Homo sapiens	deltaTm	degrees C	1.3
	8027720	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cn[nH]c(=O)c21		CHEMBL1945555	=	Delta Tm	degrees C	1.6	CHEMBL4355	Homo sapiens	deltaTm	degrees C	1.6
	8027745	CHEMBL1947279	Binding affinity to GAK assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945556	=	Delta Tm	degrees C	0.8	CHEMBL4355	Homo sapiens	deltaTm	degrees C	0.8
	8046134	CHEMBL1958951	Inhibition of GAK at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	=	Inhibition	%	100.0	CHEMBL4355	Homo sapiens	INH	%	100.0
Active	10884056	CHEMBL2033665	Binding affinity to GAK at 100 nM	B	C=CC(=O)Nc1cccc(N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL2029438		Activity			CHEMBL4355	Homo sapiens	Activity		
	10921374	CHEMBL2046178	Inhibition of GAK at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	91.0	CHEMBL4355	Homo sapiens	INH	%	91.0
	10921375	CHEMBL2046179	Inhibition of GAK at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	<	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	12155965	CHEMBL2185158	Inhibition of GAK assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179119	=	Activity	%	7.7	CHEMBL4355	Homo sapiens	Activity	%	7.7
Active	12155967	CHEMBL2185158	Inhibition of GAK assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Inhibition	%		CHEMBL4355	Homo sapiens	INH		
	12173596	CHEMBL2213535	Inhibition of GAK assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	86.0	CHEMBL4355	Homo sapiens	Activity	%	86.0
	12183882	CHEMBL2211505	Inhibition of GAK	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	pIC50		5.0
	13342307	CHEMBL2394177	Competitive binding affinity to GAK (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2ccnc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1898211	<	Activity	%	30.0	CHEMBL4355	Homo sapiens	Activity	%	30.0
	13442351	CHEMBL2429675	Competitive binding affinity to GAK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	91.0	CHEMBL4355	Homo sapiens	INH	%	91.0
	13445486	CHEMBL2429675	Competitive binding affinity to GAK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	100.0	CHEMBL4355	Homo sapiens	INH	%	100.0
	13448541	CHEMBL2429675	Competitive binding affinity to GAK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	100.0	CHEMBL4355	Homo sapiens	INH	%	100.0
	13448677	CHEMBL2429675	Competitive binding affinity to GAK (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	100.0	CHEMBL4355	Homo sapiens	INH	%	100.0
	13451472	CHEMBL2429675	Competitive binding affinity to GAK (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	91.0	CHEMBL4355	Homo sapiens	INH	%	91.0
	13454657	CHEMBL2429675	Competitive binding affinity to GAK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	100.0	CHEMBL4355	Homo sapiens	INH	%	100.0
	13895033	CHEMBL3111965	Inhibition of GAK (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109142	=	Activity	%	49.0	CHEMBL4355	Homo sapiens	Activity	%	49.0
	14664179	CHEMBL3270875	Inhibition of GAK (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	97.0	CHEMBL4355	Homo sapiens	INH	%	97.0
	14664180	CHEMBL3270875	Inhibition of GAK (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	90.0	CHEMBL4355	Homo sapiens	INH	%	90.0
	14664181	CHEMBL3270875	Inhibition of GAK (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	88.0	CHEMBL4355	Homo sapiens	INH	%	88.0
	15249574	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	Nc1snc2cc(-c3ccccc3)cnc12		CHEMBL3425834	=	Activity	%	68.0	CHEMBL4355	Homo sapiens	Activity	%	68.0
	15249575	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	Nc1snc2cc(-c3ccc(F)cc3)cnc12		CHEMBL3425835	=	Activity	%	55.0	CHEMBL4355	Homo sapiens	Activity	%	55.0
	15249576	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N)snc3c2)cc1OC		CHEMBL3425836	=	Activity	%	70.0	CHEMBL4355	Homo sapiens	Activity	%	70.0
	15249577	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	Nc1snc2cc(-c3ccsc3)cnc12		CHEMBL3425837	=	Activity	%	61.0	CHEMBL4355	Homo sapiens	Activity	%	61.0
	15249578	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	Nc1snc2cc(-c3cccnc3)cnc12		CHEMBL3425838	=	Activity	%	80.0	CHEMBL4355	Homo sapiens	Activity	%	80.0
	15249579	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	OCCNc1snc2cc(-c3ccccc3)cnc12		CHEMBL3425839	=	Activity	%	18.0	CHEMBL4355	Homo sapiens	Activity	%	18.0
	15249580	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	OCCNc1snc2cc(-c3ccc(F)cc3)cnc12		CHEMBL3425840	=	Activity	%	2.2	CHEMBL4355	Homo sapiens	Activity	%	2.2
	15249581	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NCCO)snc3c2)cc1OC		CHEMBL3425841	=	Activity	%	0.4	CHEMBL4355	Homo sapiens	Activity	%	0.4
	15249582	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	OCCNc1snc2cc(-c3ccsc3)cnc12		CHEMBL3425842	=	Activity	%	0.3	CHEMBL4355	Homo sapiens	Activity	%	0.3
	15249583	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	OCCNc1snc2cc(-c3cccnc3)cnc12		CHEMBL3425843	=	Activity	%	45.0	CHEMBL4355	Homo sapiens	Activity	%	45.0
	15249584	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	c1ccc(-c2cnc3c(N4CCOCC4)snc3c2)cc1		CHEMBL3425844	=	Activity	%	0.8	CHEMBL4355	Homo sapiens	Activity	%	0.8
	15249585	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	Fc1ccc(-c2cnc3c(N4CCOCC4)snc3c2)cc1		CHEMBL3425845	=	Activity	%	11.0	CHEMBL4355	Homo sapiens	Activity	%	11.0
	15249586	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCOCC4)snc3c2)cc1OC		CHEMBL3425846	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	15249587	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	c1cc(-c2cnc3c(N4CCOCC4)snc3c2)cs1		CHEMBL3425847	=	Activity	%	0.1	CHEMBL4355	Homo sapiens	Activity	%	0.1
	15249588	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	c1cncc(-c2cnc3c(N4CCOCC4)snc3c2)c1		CHEMBL3425848	=	Activity	%	25.0	CHEMBL4355	Homo sapiens	Activity	%	25.0
	15249589	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	CN1CCN(c2snc3cc(-c4ccccc4)cnc23)CC1		CHEMBL3425849	=	Activity	%	76.0	CHEMBL4355	Homo sapiens	Activity	%	76.0
	15249590	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	CN1CCN(c2snc3cc(-c4ccc(F)cc4)cnc23)CC1		CHEMBL3425850	=	Activity	%	72.0	CHEMBL4355	Homo sapiens	Activity	%	72.0
	15249591	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCN(C)CC4)snc3c2)cc1OC		CHEMBL3425851	=	Activity	%	19.0	CHEMBL4355	Homo sapiens	Activity	%	19.0
	15249592	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	CN1CCN(c2snc3cc(-c4ccsc4)cnc23)CC1		CHEMBL3425852	=	Activity	%	7.4	CHEMBL4355	Homo sapiens	Activity	%	7.4
	15249593	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	CN1CCN(c2snc3cc(-c4cccnc4)cnc23)CC1		CHEMBL3425853	=	Activity	%	88.0	CHEMBL4355	Homo sapiens	Activity	%	88.0
	15249594	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1snc2cc(-c3ccccc3)cnc12		CHEMBL3425854	=	Activity	%	18.0	CHEMBL4355	Homo sapiens	Activity	%	18.0
	15249595	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1snc2cc(-c3ccc(F)cc3)cnc12		CHEMBL3425855	=	Activity	%	37.0	CHEMBL4355	Homo sapiens	Activity	%	37.0
	15249596	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(OC)snc3c2)cc1OC		CHEMBL3425856	=	Activity	%	19.0	CHEMBL4355	Homo sapiens	Activity	%	19.0
	15249597	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1snc2cc(-c3ccsc3)cnc12		CHEMBL3425857	=	Activity	%	22.0	CHEMBL4355	Homo sapiens	Activity	%	22.0
	15249598	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1snc2cc(-c3cccnc3)cnc12		CHEMBL3425858	=	Activity	%	93.0	CHEMBL4355	Homo sapiens	Activity	%	93.0
	15250329	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	c1csc(-c2cnc3c(N4CCOCC4)snc3c2)c1		CHEMBL3425859	=	Activity	%	0.05	CHEMBL4355	Homo sapiens	Activity	%	0.05
	15250330	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	c1cc(-c2cnc3c(N4CCOCC4)snc3c2)co1		CHEMBL3425860	=	Activity	%	0.15	CHEMBL4355	Homo sapiens	Activity	%	0.15
	15250331	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCOCC4)snc3c2)c(OC)c1		CHEMBL3425861	=	Activity	%	6.3	CHEMBL4355	Homo sapiens	Activity	%	6.3
	15250332	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(OC)c(-c2cnc3c(N4CCOCC4)snc3c2)c1		CHEMBL3425862	=	Activity	%	0.7	CHEMBL4355	Homo sapiens	Activity	%	0.7
	15250333	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1cc(OC)cc(-c2cnc3c(N4CCOCC4)snc3c2)c1		CHEMBL3425863	=	Activity	%	0.2	CHEMBL4355	Homo sapiens	Activity	%	0.2
	15250334	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	c1cc2c(cc1-c1cnc3c(N4CCOCC4)snc3c1)OCO2		CHEMBL3425864	=	Activity	%	51.0	CHEMBL4355	Homo sapiens	Activity	%	51.0
	15250335	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	15250336	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1OC(C)=O		CHEMBL3425866	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	15250337	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1N		CHEMBL3425867	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	15250338	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1O		CHEMBL3425868	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	15250339	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N(C)C)snc3c2)cc1OC		CHEMBL3425869	=	Activity	%	0.1	CHEMBL4355	Homo sapiens	Activity	%	0.1
	15250340	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COCCNc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3425870	=	Activity	%	0.1	CHEMBL4355	Homo sapiens	Activity	%	0.1
	15250341	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N(CCO)CCO)snc3c2)cc1OC		CHEMBL3425871	=	Activity	%	4.0	CHEMBL4355	Homo sapiens	Activity	%	4.0
	15250342	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCCC4)snc3c2)cc1OC		CHEMBL3425872	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	15250343	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NCC4CC4)snc3c2)cc1OC		CHEMBL3425873	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	15250344	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCCCC4)snc3c2)cc1OC		CHEMBL3425874	=	Activity	%	2.6	CHEMBL4355	Homo sapiens	Activity	%	2.6
	15250345	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCSCC4)snc3c2)cc1OC		CHEMBL3425875	=	Activity	%	0.8	CHEMBL4355	Homo sapiens	Activity	%	0.8
	15250346	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)cc1OC		CHEMBL3425876	=	Activity	%	0.1	CHEMBL4355	Homo sapiens	Activity	%	0.1
	15250347	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCC(O)CC4)snc3c2)cc1OC		CHEMBL3425877	=	Activity	%	0.1	CHEMBL4355	Homo sapiens	Activity	%	0.1
	15250348	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC4CCOCC4)snc3c2)cc1OC		CHEMBL3425878	=	Activity	%	0.1	CHEMBL4355	Homo sapiens	Activity	%	0.1
	15250349	CHEMBL3430282	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 assessed as ligand-protein complex at 10 uM after 1 hr by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NCCc4ccccc4)snc3c2)cc1OC		CHEMBL3425879	=	Activity	%	81.0	CHEMBL4355	Homo sapiens	Activity	%	81.0
	15250350	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(NCCO)snc3c2)cc1OC		CHEMBL3425841	=	Kd	nM	120.0	CHEMBL4355	Homo sapiens	Kd	uM	0.12
	15250351	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	OCCNc1snc2cc(-c3ccsc3)cnc12		CHEMBL3425842	=	Kd	nM	300.0	CHEMBL4355	Homo sapiens	Kd	uM	0.3
	15250352	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	c1ccc(-c2cnc3c(N4CCOCC4)snc3c2)cc1		CHEMBL3425844	=	Kd	nM	500.0	CHEMBL4355	Homo sapiens	Kd	uM	0.5
	15250353	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(N4CCOCC4)snc3c2)cc1OC		CHEMBL3425846	=	Kd	nM	52.0	CHEMBL4355	Homo sapiens	Kd	uM	0.052
	15250354	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	c1cc(-c2cnc3c(N4CCOCC4)snc3c2)cs1		CHEMBL3425847	=	Kd	nM	42.0	CHEMBL4355	Homo sapiens	Kd	uM	0.042
	15250355	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	c1csc(-c2cnc3c(N4CCOCC4)snc3c2)c1		CHEMBL3425859	=	Kd	nM	47.0	CHEMBL4355	Homo sapiens	Kd	uM	0.047
	15250356	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	c1cc(-c2cnc3c(N4CCOCC4)snc3c2)co1		CHEMBL3425860	=	Kd	nM	200.0	CHEMBL4355	Homo sapiens	Kd	uM	0.2
Not Determined	15250357	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(N4CCOCC4)snc3c2)c(OC)c1		CHEMBL3425861		Kd			CHEMBL4355	Homo sapiens	Kd		
	15250358	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(OC)c(-c2cnc3c(N4CCOCC4)snc3c2)c1		CHEMBL3425862	=	Kd	nM	130.0	CHEMBL4355	Homo sapiens	Kd	uM	0.13
	15250359	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1cc(OC)cc(-c2cnc3c(N4CCOCC4)snc3c2)c1		CHEMBL3425863	=	Kd	nM	72.0	CHEMBL4355	Homo sapiens	Kd	uM	0.072
Not Determined	15250360	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	c1cc2c(cc1-c1cnc3c(N4CCOCC4)snc3c1)OCO2		CHEMBL3425864		Kd			CHEMBL4355	Homo sapiens	Kd		
	15250361	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	Kd	nM	8.3	CHEMBL4355	Homo sapiens	Kd	uM	0.0083
	15250362	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1OC(C)=O		CHEMBL3425866	=	Kd	nM	18.0	CHEMBL4355	Homo sapiens	Kd	uM	0.018
	15250363	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1N		CHEMBL3425867	=	Kd	nM	8.9	CHEMBL4355	Homo sapiens	Kd	uM	0.0089
	15250364	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1O		CHEMBL3425868	=	Kd	nM	18.0	CHEMBL4355	Homo sapiens	Kd	uM	0.018
	15250365	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(N(C)C)snc3c2)cc1OC		CHEMBL3425869	=	Kd	nM	190.0	CHEMBL4355	Homo sapiens	Kd	uM	0.19
	15250366	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COCCNc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3425870	=	Kd	nM	140.0	CHEMBL4355	Homo sapiens	Kd	uM	0.14
	15250367	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(N(CCO)CCO)snc3c2)cc1OC		CHEMBL3425871	=	Kd	nM	320.0	CHEMBL4355	Homo sapiens	Kd	uM	0.32
	15250368	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(N4CCCC4)snc3c2)cc1OC		CHEMBL3425872	=	Kd	nM	100.0	CHEMBL4355	Homo sapiens	Kd	uM	0.1
	15250369	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(NCC4CC4)snc3c2)cc1OC		CHEMBL3425873	=	Kd	nM	27.0	CHEMBL4355	Homo sapiens	Kd	uM	0.027
	15250370	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(N4CCCCC4)snc3c2)cc1OC		CHEMBL3425874	=	Kd	nM	270.0	CHEMBL4355	Homo sapiens	Kd	uM	0.27
	15250371	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(N4CCSCC4)snc3c2)cc1OC		CHEMBL3425875	=	Kd	nM	230.0	CHEMBL4355	Homo sapiens	Kd	uM	0.23
	15250372	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)cc1OC		CHEMBL3425876	=	Kd	nM	110.0	CHEMBL4355	Homo sapiens	Kd	uM	0.11
	15250373	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(N4CCC(O)CC4)snc3c2)cc1OC		CHEMBL3425877	=	Kd	nM	63.0	CHEMBL4355	Homo sapiens	Kd	uM	0.063
	15250374	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(NC4CCOCC4)snc3c2)cc1OC		CHEMBL3425878	=	Kd	nM	88.0	CHEMBL4355	Homo sapiens	Kd	uM	0.088
Not Determined	15250375	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1ccc(-c2cnc3c(NCCc4ccccc4)snc3c2)cc1OC		CHEMBL3425879		Kd			CHEMBL4355	Homo sapiens	Kd		
	15250376	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2.6	CHEMBL4355	Homo sapiens	Kd	nM	2.6
	15250377	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	13.0	CHEMBL4355	Homo sapiens	Kd	nM	13.0
	15250378	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	6.4	CHEMBL4355	Homo sapiens	Kd	nM	6.4
	15250379	CHEMBL3430283	Binding affinity to human GAK fused to T7 bacteriophage expressed in Escherichia coli BL21 after 1 hr by qPCR analysis	B	CCc1nc2sc(C)c(C)c2c(=O)n1N		CHEMBL3425880	=	Kd	nM	2000.0	CHEMBL4355	Homo sapiens	Kd	uM	2.0
	15250404	CHEMBL3428180	Inhibition of GAK (unknown origin)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	105.0	CHEMBL4355	Homo sapiens	IC50	nM	105.0
	15250405	CHEMBL3428181	Binding affinity to human GAK fused to T7 bacteriophage after 1 hr by qPCR analysis	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3.1	CHEMBL4355	Homo sapiens	Kd	nM	3.1
Dose-dependent effect	15250424	CHEMBL3428327	Inhibition of GAK in human Huh7.5 cells assessed as reduction of phosphorylated AP2M1 to total AP2M1 ratio after 1 hr by Western blot analysis in presence of PP2A inhibitor calyculin A	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865		Inhibition	%		CHEMBL4355	Homo sapiens	INH		
Dose-dependent effect	15250425	CHEMBL3428327	Inhibition of GAK in human Huh7.5 cells assessed as reduction of phosphorylated AP2M1 to total AP2M1 ratio after 1 hr by Western blot analysis in presence of PP2A inhibitor calyculin A	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1N		CHEMBL3425867		Inhibition	%		CHEMBL4355	Homo sapiens	INH		
	15250426	CHEMBL3428328	Inhibition of GAK in human Huh7.5 cells assessed as reduction of phosphorylated AP2M1 to total AP2M1 ratio at 1 uM after 1 hr by Western blot analysis in presence of PP2A inhibitor calyculin A relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	FC		0.55	CHEMBL4355	Homo sapiens	FC		0.55
	15250427	CHEMBL3428328	Inhibition of GAK in human Huh7.5 cells assessed as reduction of phosphorylated AP2M1 to total AP2M1 ratio at 1 uM after 1 hr by Western blot analysis in presence of PP2A inhibitor calyculin A relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1N		CHEMBL3425867	=	FC		0.3	CHEMBL4355	Homo sapiens	FC		0.3
	15250428	CHEMBL3428329	Inhibition of GAK in human Huh7.5 cells assessed as reduction of phosphorylated AP2M1 to total AP2M1 ratio at 5 uM after 1 hr by Western blot analysis in presence of PP2A inhibitor calyculin A relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	FC		0.4	CHEMBL4355	Homo sapiens	FC		0.4
	15250429	CHEMBL3428329	Inhibition of GAK in human Huh7.5 cells assessed as reduction of phosphorylated AP2M1 to total AP2M1 ratio at 5 uM after 1 hr by Western blot analysis in presence of PP2A inhibitor calyculin A relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1N		CHEMBL3425867	=	FC		0.07	CHEMBL4355	Homo sapiens	FC		0.07
	15667034	CHEMBL3603236	Inhibition of GAK (unknown origin) assessed as residual enzyme activity at 1 uM by Z'-Lyte assay relative to control	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223	=	Activity	%	5.4	CHEMBL4355	Homo sapiens	Activity	%	5.4
	15771604	CHEMBL3635829	Competitive binding affinity to human GAK in presence of immobilized ligand	B	C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(OCCN(C)C)cc4OC)nc32)c1		CHEMBL3633152	=	Kd	nM	430.0	CHEMBL4355	Homo sapiens	Kd	nM	430.0
	16445483	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(C)=O)snc3c2)cc1OC		CHEMBL3753498	=	Activity	%	54.0	CHEMBL4355	Homo sapiens	Activity	%	54.0
	16445484	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	CCC(=O)Nc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3753200	=	Activity	%	15.0	CHEMBL4355	Homo sapiens	Activity	%	15.0
	16445485	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C(C)C)snc3c2)cc1OC		CHEMBL3754294	=	Activity	%	29.0	CHEMBL4355	Homo sapiens	Activity	%	29.0
	16445486	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C(C)(C)C)snc3c2)cc1OC		CHEMBL3753323	=	Activity	%	66.0	CHEMBL4355	Homo sapiens	Activity	%	66.0
	16445487	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	CCC(CC)C(=O)Nc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3754045	=	Activity	%	90.0	CHEMBL4355	Homo sapiens	Activity	%	90.0
	16445488	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C4CC4)snc3c2)cc1OC		CHEMBL3753527	=	Activity	%	2.3	CHEMBL4355	Homo sapiens	Activity	%	2.3
	16445489	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C4CC=CC4)snc3c2)cc1OC		CHEMBL3752526	=	Activity	%	15.0	CHEMBL4355	Homo sapiens	Activity	%	15.0
	16445490	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C4CCCCCC4)snc3c2)cc1OC		CHEMBL3753615	=	Activity	%	88.0	CHEMBL4355	Homo sapiens	Activity	%	88.0
	16445491	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C4CCOCC4)snc3c2)cc1OC		CHEMBL3752800	=	Activity	%	58.0	CHEMBL4355	Homo sapiens	Activity	%	58.0
	16445492	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)c4ccccc4)snc3c2)cc1OC		CHEMBL3752472	=	Activity	%	2.2	CHEMBL4355	Homo sapiens	Activity	%	2.2
	16445493	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(OC(C)C)snc3c2)cc1OC		CHEMBL3753017	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	16445494	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	CCC(C)Oc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3754235	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	16445495	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	CCCCOc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3753916	=	Activity	%	0.8	CHEMBL4355	Homo sapiens	Activity	%	0.8
	16445496	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	CCCCCOc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3751860	=	Activity	%	27.0	CHEMBL4355	Homo sapiens	Activity	%	27.0
	16445497	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(OCCC(C)C)snc3c2)cc1OC		CHEMBL3752816	=	Activity	%	4.7	CHEMBL4355	Homo sapiens	Activity	%	4.7
	16445498	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(OC4CCCCC4)snc3c2)cc1OC		CHEMBL3753095	=	Activity	%	0.95	CHEMBL4355	Homo sapiens	Activity	%	0.95
	16445499	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	CCOc1snc2cc(-c3ccsc3)cnc12		CHEMBL3754728	=	Activity	%	0.55	CHEMBL4355	Homo sapiens	Activity	%	0.55
	16445500	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	CC(C)Oc1snc2cc(-c3ccsc3)cnc12		CHEMBL3753050	=	Activity	%	0.11	CHEMBL4355	Homo sapiens	Activity	%	0.11
	16445501	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCN(C(C)C)CC4)snc3c2)cc1OC		CHEMBL3754693	=	Activity	%	11.0	CHEMBL4355	Homo sapiens	Activity	%	11.0
	16445502	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	CCCCN1CCN(c2snc3cc(-c4ccc(OC)c(OC)c4)cnc23)CC1		CHEMBL3753766	=	Activity	%	52.0	CHEMBL4355	Homo sapiens	Activity	%	52.0
	16445503	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCN(c5ccncc5)CC4)snc3c2)cc1OC		CHEMBL3752023	=	Activity	%	23.0	CHEMBL4355	Homo sapiens	Activity	%	23.0
	16445504	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCN(C(C)=O)CC4)snc3c2)cc1OC		CHEMBL3754300	=	Activity	%	0.7	CHEMBL4355	Homo sapiens	Activity	%	0.7
	16445505	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	CCOC(=O)N1CCN(c2snc3cc(-c4ccc(OC)c(OC)c4)cnc23)CC1		CHEMBL3751921	=	Activity	%	5.0	CHEMBL4355	Homo sapiens	Activity	%	5.0
	16445506	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCN(C(=O)c5ccccc5)CC4)snc3c2)cc1OC		CHEMBL3754725	=	Activity	%	12.0	CHEMBL4355	Homo sapiens	Activity	%	12.0
	16445507	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCCN(C)CC4)snc3c2)cc1OC		CHEMBL3753857	=	Activity	%	0.4	CHEMBL4355	Homo sapiens	Activity	%	0.4
	16445508	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC4CCNCC4)snc3c2)cc1OC		CHEMBL3753792	=	Activity	%	0.25	CHEMBL4355	Homo sapiens	Activity	%	0.25
	16445509	CHEMBL3755229	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand at 10 uM by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCC(C)CC4)snc3c2)cc1OC		CHEMBL3753335	=	Activity	%	2.0	CHEMBL4355	Homo sapiens	Activity	%	2.0
Not Determined	16445510	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(C)=O)snc3c2)cc1OC		CHEMBL3753498		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Determined	16445511	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	CCC(=O)Nc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3753200		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Determined	16445512	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C(C)C)snc3c2)cc1OC		CHEMBL3754294		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Determined	16445513	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C(C)(C)C)snc3c2)cc1OC		CHEMBL3753323		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Determined	16445514	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	CCC(CC)C(=O)Nc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3754045		Kd			CHEMBL4355	Homo sapiens	Kd		
	16445515	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C4CC4)snc3c2)cc1OC		CHEMBL3753527	=	Kd	nM	1100.0	CHEMBL4355	Homo sapiens	Kd	uM	1.1
Not Determined	16445516	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C4CC=CC4)snc3c2)cc1OC		CHEMBL3752526		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Determined	16445517	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C4CCCCCC4)snc3c2)cc1OC		CHEMBL3753615		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Determined	16445518	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)C4CCOCC4)snc3c2)cc1OC		CHEMBL3752800		Kd			CHEMBL4355	Homo sapiens	Kd		
	16445519	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC(=O)c4ccccc4)snc3c2)cc1OC		CHEMBL3752472	=	Kd	nM	600.0	CHEMBL4355	Homo sapiens	Kd	uM	0.6
	16445520	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(OC(C)C)snc3c2)cc1OC		CHEMBL3753017	=	Kd	nM	85.0	CHEMBL4355	Homo sapiens	Kd	uM	0.085
	16445521	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	CCC(C)Oc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3754235	=	Kd	nM	74.0	CHEMBL4355	Homo sapiens	Kd	uM	0.074
	16445522	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	CCCCOc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3753916	=	Kd	nM	310.0	CHEMBL4355	Homo sapiens	Kd	uM	0.31
Not Determined	16445523	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	CCCCCOc1snc2cc(-c3ccc(OC)c(OC)c3)cnc12		CHEMBL3751860		Kd			CHEMBL4355	Homo sapiens	Kd		
	16445524	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(OCCC(C)C)snc3c2)cc1OC		CHEMBL3752816	=	Kd	nM	590.0	CHEMBL4355	Homo sapiens	Kd	uM	0.59
	16445525	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(OC4CCCCC4)snc3c2)cc1OC		CHEMBL3753095	=	Kd	nM	340.0	CHEMBL4355	Homo sapiens	Kd	uM	0.34
	16445527	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	CCOc1snc2cc(-c3ccsc3)cnc12		CHEMBL3754728	=	Kd	nM	220.0	CHEMBL4355	Homo sapiens	Kd	uM	0.22
	16445528	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	CC(C)Oc1snc2cc(-c3ccsc3)cnc12		CHEMBL3753050	=	Kd	nM	110.0	CHEMBL4355	Homo sapiens	Kd	uM	0.11
Not Determined	16445529	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCN(C(C)C)CC4)snc3c2)cc1OC		CHEMBL3754693		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Determined	16445530	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	CCCCN1CCN(c2snc3cc(-c4ccc(OC)c(OC)c4)cnc23)CC1		CHEMBL3753766		Kd			CHEMBL4355	Homo sapiens	Kd		
Not Determined	16445531	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCN(c5ccncc5)CC4)snc3c2)cc1OC		CHEMBL3752023		Kd			CHEMBL4355	Homo sapiens	Kd		
	16445532	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCN(C(C)=O)CC4)snc3c2)cc1OC		CHEMBL3754300	=	Kd	nM	290.0	CHEMBL4355	Homo sapiens	Kd	uM	0.29
	16445533	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	CCOC(=O)N1CCN(c2snc3cc(-c4ccc(OC)c(OC)c4)cnc23)CC1		CHEMBL3751921	=	Kd	nM	610.0	CHEMBL4355	Homo sapiens	Kd	uM	0.61
Not Determined	16445534	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCN(C(=O)c5ccccc5)CC4)snc3c2)cc1OC		CHEMBL3754725		Kd			CHEMBL4355	Homo sapiens	Kd		
	16445535	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCCN(C)CC4)snc3c2)cc1OC		CHEMBL3753857	=	Kd	nM	900.0	CHEMBL4355	Homo sapiens	Kd	uM	0.9
	16445536	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(NC4CCNCC4)snc3c2)cc1OC		CHEMBL3753792	=	Kd	nM	640.0	CHEMBL4355	Homo sapiens	Kd	uM	0.64
	16445537	CHEMBL3755230	Binding affinity to DNA-tagged GAK (unknown origin) assessed as binding of DNA-tagged-GAK to immobilized ligand by qPCR analysis relative to control	B	COc1ccc(-c2cnc3c(N4CCC(C)CC4)snc3c2)cc1OC		CHEMBL3753335	=	Kd	nM	660.0	CHEMBL4355	Homo sapiens	Kd	uM	0.66
	16472955	CHEMBL3768606	Inhibition of human GAK	B	COCCOc1cc2c(-n3nc(-c4ccccn4)nc3N)ncnc2cc1OC		CHEMBL3763358	>	Inhibition	%	95.0	CHEMBL4355	Homo sapiens	INH	%	95.0
	16578337	CHEMBL3804391	Inhibition of partial length wild type human GAK expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	78.0	CHEMBL4355	Homo sapiens	Activity	%	78.0
Active	17904203	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	=	Kd	nM	168.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	168.0
Inactive	17904204	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904205	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904206	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904207	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904208	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	694.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	694.0
Inactive	17904209	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904210	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904211	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904212	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904213	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904214	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904215	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904216	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904217	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904218	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904219	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	=	Kd	nM	8634.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	8634.0
Inactive	17904220	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904221	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	=	Kd	nM	1464.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1464.0
Inactive	17904222	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904223	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904224	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	196.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	196.0
Inactive	17904225	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904226	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904227	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904228	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904229	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904230	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	2194.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	2194.0
Inactive	17904231	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904232	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	=	Kd	nM	725.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	725.0
Inactive	17904233	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904234	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904235	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	517.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	517.0
Inactive	17904236	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904237	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904238	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	46.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	46.0
Inactive	17904239	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904240	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904241	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	2820.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	2820.0
Inactive	17904242	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904243	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904244	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	822.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	822.0
Inactive	17904245	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904246	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904247	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904248	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904249	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904250	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904251	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904252	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904253	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904254	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904255	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904256	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1878.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1878.0
Active	17904257	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	2.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	2.0
Inactive	17904258	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904259	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1351.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1351.0
Inactive	17904260	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904261	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904262	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904263	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904264	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904265	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904266	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904267	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904268	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904269	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	=	Kd	nM	27114.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	27114.0
Active	17904270	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	7442.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	7442.0
Inactive	17904271	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904272	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904273	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904274	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904275	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904276	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904277	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	Kd	nM	259.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	259.0
Inactive	17904278	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904279	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	160.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	160.0
Active	17904280	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	=	Kd	nM	658.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	658.0
Inactive	17904281	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904282	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	=	Kd	nM	418.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	418.0
Inactive	17904283	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904284	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904285	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	50.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	50.0
Inactive	17904286	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904287	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904288	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	=	Kd	nM	120.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	120.0
Active	17904289	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	108.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	108.0
Active	17904290	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	=	Kd	nM	156.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	156.0
Inactive	17904291	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904292	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904293	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904294	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904295	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904296	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	202.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	202.0
Inactive	17904297	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904298	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904299	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904300	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	5.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	5.0
Inactive	17904301	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904302	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	951.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	951.0
Inactive	17904303	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904304	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904305	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904306	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904307	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904308	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904309	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904310	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904311	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904312	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904313	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904314	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904315	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904316	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1287.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1287.0
Active	17904317	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Kd	nM	495.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	495.0
Inactive	17904318	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904319	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	4816.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	4816.0
Inactive	17904320	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904321	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904322	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904323	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904324	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904325	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904326	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904327	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904328	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	Kd	nM	482.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	482.0
Inactive	17904329	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904330	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904331	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904332	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904333	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	9.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	9.0
Active	17904334	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	674.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	674.0
Uncertain	17904335	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2702.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	2702.0
Inactive	17904336	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904337	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	3.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	3.0
Inactive	17904338	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904339	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904340	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904341	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904342	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904343	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904344	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904345	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904346	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904347	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904348	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	4862.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	4862.0
Inactive	17904349	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904350	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904351	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904352	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904353	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904354	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904355	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	176.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	176.0
Inactive	17904356	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904357	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904358	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904359	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904360	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904361	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904362	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904363	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	1954.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1954.0
Inactive	17904364	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904365	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904366	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904367	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	1862.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1862.0
Active	17904368	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	552.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	552.0
Inactive	17904369	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904370	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	615.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	615.0
Active	17904371	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	1771.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1771.0
Inactive	17904372	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904373	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904374	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904375	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	5155.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	5155.0
Inactive	17904376	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904377	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904378	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904379	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904380	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904381	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904382	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904383	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904384	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904385	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904386	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904387	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904388	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904389	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904390	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	824.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	824.0
Inactive	17904391	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904392	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904393	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904394	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904395	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	42.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	42.0
Inactive	17904396	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904397	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	=	Kd	nM	450.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	450.0
Inactive	17904398	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904399	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904400	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904401	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904402	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	2407.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	2407.0
Inactive	17904403	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904404	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	2090.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	2090.0
Inactive	17904405	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904406	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904407	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904408	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904409	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904410	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904411	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904412	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904413	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904414	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904415	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904416	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904417	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904418	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	4.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	4.0
Active	17904419	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	=	Kd	nM	4968.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	4968.0
Active	17904420	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	0.3	CHEMBL4355	Homo sapiens	Kd apparent	nM	0.3
Inactive	17904421	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904422	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904423	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904424	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1610.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1610.0
Inactive	17904425	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904426	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904427	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	1761.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1761.0
Inactive	17904428	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904429	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	23.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	23.0
Active	17904430	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	=	Kd	nM	28651.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	28651.0
Inactive	17904431	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904432	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	1269.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	1269.0
Inactive	17904433	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904434	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904435	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904436	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904437	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Active	17904438	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	117.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	117.0
Inactive	17904439	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904440	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904441	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904442	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904443	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904444	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17904445	CHEMBL3991722	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd apparent	nM	30000.0
	18114334	CHEMBL4025160	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	99.0	CHEMBL4355	Homo sapiens	Activity	%	99.0
	18203684	CHEMBL4043971	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	96.0	CHEMBL4355	Homo sapiens	Activity	%	96.0
	18253606	CHEMBL4055087	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	91.0	CHEMBL4355	Homo sapiens	Activity	%	91.0
	18253607	CHEMBL4055087	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4355	Homo sapiens	Activity	%	100.0
Active	18275823	CHEMBL4118783	Binding affinity to GAK in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4355	Homo sapiens	Activity		
Active	18275966	CHEMBL4118926	Binding affinity to GAK in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4355	Homo sapiens	Activity		
	18379198	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1N		CHEMBL3425867	=	Kd	nM	8.9	CHEMBL4355	Homo sapiens	Kd	uM	0.0089
	18379199	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCCCC4)snc3c2)ccc1N		CHEMBL4166209	=	Kd	nM	970.0	CHEMBL4355	Homo sapiens	Kd	uM	0.97
	18379200	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCC(F)(F)CC4)snc3c2)ccc1N		CHEMBL4170698	=	Kd	nM	4300.0	CHEMBL4355	Homo sapiens	Kd	uM	4.3
	18379201	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCC(N)CC4)snc3c2)ccc1N		CHEMBL4162766	=	Kd	nM	1600.0	CHEMBL4355	Homo sapiens	Kd	uM	1.6
	18379202	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCC(C(N)=O)CC4)snc3c2)ccc1N		CHEMBL4167311	=	Kd	nM	7200.0	CHEMBL4355	Homo sapiens	Kd	uM	7.2
	18379203	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCC(C#N)CC4)snc3c2)ccc1N		CHEMBL4159403	=	Kd	nM	250.0	CHEMBL4355	Homo sapiens	Kd	uM	0.25
	18379204	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCCC(C(N)=O)C4)snc3c2)ccc1N		CHEMBL4160425	=	Kd	nM	160.0	CHEMBL4355	Homo sapiens	Kd	uM	0.16
	18379205	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCS(=O)(=O)CC4)snc3c2)ccc1N		CHEMBL4168337	=	Kd	nM	210.0	CHEMBL4355	Homo sapiens	Kd	uM	0.21
	18379206	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(NC4CCOCC4)snc3c2)ccc1N		CHEMBL4163801	=	Kd	nM	80.0	CHEMBL4355	Homo sapiens	Kd	uM	0.08
	18379207	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCNC(=O)C4)snc3c2)ccc1N		CHEMBL4171678	=	Kd	nM	52.0	CHEMBL4355	Homo sapiens	Kd	uM	0.052
Active	18379258	CHEMBL4145351	Inhibition of GAK in human HuH7 cells assessed as reduction in AP2M1 phosphorylation levels up to 10 uM after 4 hrs in presence of PP2A inhibitor calyculin A by Western blot analysis	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1N		CHEMBL4172550		Inhibition	%		CHEMBL4355	Homo sapiens	INH		
	18379341	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3.1	CHEMBL4355	Homo sapiens	Kd	nM	3.1
	18379342	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4C[C@@H](C)O[C@H](C)C4)snc3c2)ccc1N		CHEMBL4165336	=	Kd	nM	11.0	CHEMBL4355	Homo sapiens	Kd	uM	0.011
	18379343	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1N		CHEMBL4172550	=	Kd	nM	89.0	CHEMBL4355	Homo sapiens	Kd	uM	0.089
	18379344	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCOC[C@H]4C)snc3c2)ccc1N		CHEMBL4161901	=	Kd	nM	800.0	CHEMBL4355	Homo sapiens	Kd	uM	0.8
	18379345	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCOC[C@@H]4C)snc3c2)ccc1N		CHEMBL4169166	=	Kd	nM	18.0	CHEMBL4355	Homo sapiens	Kd	uM	0.018
	18379346	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCOC(C)(C)C4)snc3c2)ccc1N		CHEMBL4177020	=	Kd	nM	35.0	CHEMBL4355	Homo sapiens	Kd	uM	0.035
	18379347	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCO[C@H](C)C4)snc3c2)ccc1N		CHEMBL4163357	=	Kd	nM	19.0	CHEMBL4355	Homo sapiens	Kd	uM	0.019
	18379348	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCO[C@@H](C)C4)snc3c2)ccc1N		CHEMBL4174075	=	Kd	nM	26.0	CHEMBL4355	Homo sapiens	Kd	uM	0.026
	18379349	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCOC(C)C4)snc3c2)ccc1N		CHEMBL4159994	=	Kd	nM	46.0	CHEMBL4355	Homo sapiens	Kd	uM	0.046
	18379350	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CC5CCC(C4)O5)snc3c2)ccc1N		CHEMBL4170643	=	Kd	nM	61.0	CHEMBL4355	Homo sapiens	Kd	uM	0.061
	18379351	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CC5(COC5)C4)snc3c2)ccc1N		CHEMBL4175117	=	Kd	nM	170.0	CHEMBL4355	Homo sapiens	Kd	uM	0.17
	18379352	CHEMBL4145343	Binding affinity to DNA-tagged human GAK expressed in Escherichia coli BL21 using immobilised ligand incubated for 1 hr by quantitative PCR	B	COc1cc(-c2cnc3c(N4CCCOCC4)snc3c2)ccc1N		CHEMBL4167255	=	Kd	nM	190.0	CHEMBL4355	Homo sapiens	Kd	uM	0.19
	18440226	CHEMBL4157050	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	98.0	CHEMBL4355	Homo sapiens	Activity	%	98.0
	18484182	CHEMBL4185829	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	82.0	CHEMBL4355	Homo sapiens	Activity	%	82.0
	18484666	CHEMBL4185829	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	99.0	CHEMBL4355	Homo sapiens	Activity	%	99.0
	18655506	CHEMBL4230729	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	82.0	CHEMBL4355	Homo sapiens	Activity	%	82.0
	18751585	CHEMBL4264318	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL4355	Homo sapiens	Activity	%	100.0
	18850840	CHEMBL4305763	Binding affinity to biotinylated GAK (unknown origin) incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based binding displacement assay	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	IC50	nM	3250.0	CHEMBL4355	Homo sapiens	IC50	uM	3.25
	18850841	CHEMBL4305763	Binding affinity to biotinylated GAK (unknown origin) incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based binding displacement assay	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Ki	nM	1750.0	CHEMBL4355	Homo sapiens	Ki	uM	1.75
	18857984	CHEMBL4307830	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	94.0	CHEMBL4355	Homo sapiens	Activity	%	94.0
	18893641	CHEMBL4315129	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system at 5 uM by Kinomescan method relative to control	B	CCN(CC)CCCNc1nc(/C=C/c2ccc(OC)cc2)nc2ccc(Br)cc12		CHEMBL4458349	=	Activity	%	65.0	CHEMBL4355	Homo sapiens	Activity	%	65.0
	18951225	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(CCc4ccccc4)snc3c2)cc1OC		CHEMBL4525511	=	Kd	nM	3200.0	CHEMBL4355	Homo sapiens	Kd	uM	3.2
	18951226	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(C#CC(C)C)snc3c2)cc1OC		CHEMBL4454241	=	Kd	nM	3200.0	CHEMBL4355	Homo sapiens	Kd	uM	3.2
	18951227	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(C#Cc4cccnc4)snc3c2)cc1OC		CHEMBL4522263	=	Kd	nM	7600.0	CHEMBL4355	Homo sapiens	Kd	uM	7.6
	18951228	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(C#Cc4ccccc4)snc3c2)cc1OC		CHEMBL4517342	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd	uM	30.0
	18951229	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(-c4ccc(OC)c(OC)c4)snc3c2)cc1OC		CHEMBL4558505	=	Kd	nM	41.0	CHEMBL4355	Homo sapiens	Kd	uM	0.041
	18951230	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COC(=O)c1ccc(-c2snc3cc(-c4ccc(OC)c(OC)c4)cnc23)cc1		CHEMBL4463819	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd	uM	30.0
	18951231	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(/C=C/c4ccccc4)snc3c2)cc1OC		CHEMBL4451350	=	Kd	nM	2000.0	CHEMBL4355	Homo sapiens	Kd	uM	2.0
	18951232	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(-c4ccc(C#N)cc4)snc3c2)cc1OC		CHEMBL4461988	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd	uM	30.0
	18951233	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(-c4cccc(C)c4)snc3c2)cc1OC		CHEMBL4529993	=	Kd	nM	400.0	CHEMBL4355	Homo sapiens	Kd	uM	0.4
	18951234	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(-c4ccsc4)snc3c2)cc1OC		CHEMBL4579614	=	Kd	nM	860.0	CHEMBL4355	Homo sapiens	Kd	uM	0.86
	18951235	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(-c4ccncc4)snc3c2)cc1OC		CHEMBL4574041	=	Kd	nM	520.0	CHEMBL4355	Homo sapiens	Kd	uM	0.52
	18951236	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(-c4ccccc4)snc3c2)cc1OC		CHEMBL4576567	=	Kd	nM	770.0	CHEMBL4355	Homo sapiens	Kd	uM	0.77
	18951237	CHEMBL4331519	Binding affinity to wild type DNA-tagged human GAK (G13 to Y338 residues) expressed in bacterial expression system by quantitative PCR based KINOMEscan assay	B	COc1ccc(-c2cnc3c(N4CCOCC4)snc3c2)cc1OC		CHEMBL3425846	=	Kd	nM	52.0	CHEMBL4355	Homo sapiens	Kd	uM	0.052
	18958897	CHEMBL4333419	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	24.0	CHEMBL4355	Homo sapiens	Activity	%	24.0
	18976092	CHEMBL4338239	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by active-site directed competition binding assay based Kinomescan method	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Kd	nM	440.0	CHEMBL4355	Homo sapiens	Kd	uM	0.44
	19009154	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12)C1CC1		CHEMBL4516665	=	Ki	nM	1600.0	CHEMBL4355	Homo sapiens	Ki	nM	1600.0
	19009155	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452360	=	Ki	nM	2600.0	CHEMBL4355	Homo sapiens	Ki	nM	2600.0
	19009156	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4534959	=	Ki	nM	870.0	CHEMBL4355	Homo sapiens	Ki	nM	870.0
	19009157	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	=	Ki	nM	1700.0	CHEMBL4355	Homo sapiens	Ki	nM	1700.0
	19009158	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CC(C)CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4571548	=	Ki	nM	1300.0	CHEMBL4355	Homo sapiens	Ki	nM	1300.0
	19009159	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCCS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4552310	=	Ki	nM	1100.0	CHEMBL4355	Homo sapiens	Ki	nM	1100.0
	19009160	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccc(F)cc4)c3)ccc12)C1CC1		CHEMBL4534571	=	Ki	nM	7000.0	CHEMBL4355	Homo sapiens	Ki	nM	7000.0
	19009161	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccccc4F)c3)ccc12)C1CC1		CHEMBL4473140	=	Ki	nM	4600.0	CHEMBL4355	Homo sapiens	Ki	nM	4600.0
	19009162	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4cccc(F)c4)c3)ccc12)C1CC1		CHEMBL4593649	=	Ki	nM	4600.0	CHEMBL4355	Homo sapiens	Ki	nM	4600.0
	19009163	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CCC4)c3)ccc12)C1CC1		CHEMBL4535040	=	Ki	nM	2900.0	CHEMBL4355	Homo sapiens	Ki	nM	2900.0
	19009164	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CCC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4447403	=	Ki	nM	510.0	CHEMBL4355	Homo sapiens	Ki	nM	510.0
	19009165	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CN(CC(F)(F)F)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4561238	=	Ki	nM	780.0	CHEMBL4355	Homo sapiens	Ki	nM	780.0
	19009166	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4582326	=	Ki	nM	580.0	CHEMBL4355	Homo sapiens	Ki	nM	580.0
	19009167	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CC(C)CS(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4522276	=	Ki	nM	3900.0	CHEMBL4355	Homo sapiens	Ki	nM	3900.0
	19009168	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(CC)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4472438	=	Ki	nM	3200.0	CHEMBL4355	Homo sapiens	Ki	nM	3200.0
	19009169	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4542463	=	Ki	nM	3200.0	CHEMBL4355	Homo sapiens	Ki	nM	3200.0
	19009170	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(C)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4470026	=	Ki	nM	360.0	CHEMBL4355	Homo sapiens	Ki	nM	360.0
	19009171	CHEMBL4345185	Displacement of Alexafluor labelled kinase tracer236 from biotinylated C-terminal Avi-tagged GAK kinase domain (12 to 347 residues) (unknown origin) expressed in Escherichia coli measured after 1.5 hrs by TR-FRET assay	B	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452939	=	Ki	nM	1700.0	CHEMBL4355	Homo sapiens	Ki	nM	1700.0
	19009222	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CC4)c3)ccc12)C1CC1		CHEMBL4516665	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009223	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009224	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CC(C)CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4571548	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009225	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCCS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4552310	=	IC50	nM	9250.0	CHEMBL4355	Homo sapiens	IC50	nM	9250.0
	19009226	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccc(F)cc4)c3)ccc12)C1CC1		CHEMBL4534571	=	IC50	nM	9240.0	CHEMBL4355	Homo sapiens	IC50	nM	9240.0
	19009227	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4ccccc4F)c3)ccc12)C1CC1		CHEMBL4473140	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009228	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)Cc4cccc(F)c4)c3)ccc12)C1CC1		CHEMBL4593649	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009229	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(NS(=O)(=O)C4CCC4)c3)ccc12)C1CC1		CHEMBL4535040	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009230	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CCC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4447403	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009231	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CN(CC(F)(F)F)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4561238	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009232	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC(F)(F)F)c3)ccc12)C1CC1		CHEMBL4582326	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009233	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CC(C)CS(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4522276	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009234	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(CC)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4472438	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009235	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	O=C(Nc1n[nH]c2cc(-c3cccc(CNS(=O)(=O)CC4CC4)c3)ccc12)C1CC1		CHEMBL4542463	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009236	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(C)S(=O)(=O)NCc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4470026	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19009237	CHEMBL4345189	Inhibition of tracer K5 binding to N-terminal nano luciferase-fused GAK (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition and measured within 10 mins by NanoBRET assay	B	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452939	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	19059606	CHEMBL4357907	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	0.0	CHEMBL4355	Homo sapiens	Activity	%	0.0
	19090174	CHEMBL4365748	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	92.0	CHEMBL4355	Homo sapiens	Activity	%	92.0
	19114487	CHEMBL4371433	Binding affinity to GAK in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	2448.0	CHEMBL4355	Homo sapiens	Kd(free)	uM	2.448
	19114705	CHEMBL4371433	Binding affinity to GAK in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	4166.0	CHEMBL4355	Homo sapiens	Kd(free)	uM	4.166
	19159434	CHEMBL4382538	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	29.0	CHEMBL4355	Homo sapiens	Activity	%	29.0
	19191573	CHEMBL4389257	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	24.0	CHEMBL4355	Homo sapiens	INH	%	24.0
	19191920	CHEMBL4389734	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	96.0	CHEMBL4355	Homo sapiens	INH	%	96.0
	19199870	CHEMBL4391360	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	19.0	CHEMBL4355	Homo sapiens	Activity	%	19.0
	19218761	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	0.3	CHEMBL4355	Homo sapiens	Kd	nM	0.3
	19218762	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	100.0	CHEMBL4355	Homo sapiens	Kd	nM	100.0
	19218763	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1.3	CHEMBL4355	Homo sapiens	Kd	nM	1.3
	19218764	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	250.0	CHEMBL4355	Homo sapiens	Kd	nM	250.0
	19218765	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	86.0	CHEMBL4355	Homo sapiens	Kd	nM	86.0
	19218766	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	79.0	CHEMBL4355	Homo sapiens	Kd	nM	79.0
	19218767	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	13.0	CHEMBL4355	Homo sapiens	Kd	nM	13.0
	19218768	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	=	Kd	nM	31.0	CHEMBL4355	Homo sapiens	Kd	nM	31.0
	19218769	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc(Nc2ncnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4446630	=	Kd	nM	190.0	CHEMBL4355	Homo sapiens	Kd	nM	190.0
	19218770	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL309682	=	Kd	nM	10.0	CHEMBL4355	Homo sapiens	Kd	nM	10.0
	19218771	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL81073	=	Kd	nM	0.42	CHEMBL4355	Homo sapiens	Kd	nM	0.42
	19218772	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	C#Cc1cccc(Nc2ccnc3cc(OC)c(OC)cc23)c1		CHEMBL1092250	=	Kd	nM	7.6	CHEMBL4355	Homo sapiens	Kd	nM	7.6
	19218773	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL304929	=	Kd	nM	6.8	CHEMBL4355	Homo sapiens	Kd	nM	6.8
	19218774	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	C#Cc1cccc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c1		CHEMBL4440586	=	Kd	nM	2.6	CHEMBL4355	Homo sapiens	Kd	nM	2.6
	19218775	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COCCOc1cc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OCCOC		CHEMBL4468521	=	Kd	nM	150.0	CHEMBL4355	Homo sapiens	Kd	nM	150.0
	19218776	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3.1	CHEMBL4355	Homo sapiens	Kd	nM	3.1
	19218777	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	C#Cc1cccc(Nc2ccnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL1089203	=	Kd	nM	1200.0	CHEMBL4355	Homo sapiens	Kd	nM	1200.0
	19218778	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2nccc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL98248	=	Kd	nM	240.0	CHEMBL4355	Homo sapiens	Kd	nM	240.0
	19218779	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1OC		CHEMBL111038	=	Kd	nM	12.0	CHEMBL4355	Homo sapiens	Kd	nM	12.0
	19218780	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2nccc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OC		CHEMBL4447797	>	Kd	nM	10000.0	CHEMBL4355	Homo sapiens	Kd	nM	10000.0
	19218781	CHEMBL4394507	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OC		CHEMBL4467033	=	Kd	nM	5000.0	CHEMBL4355	Homo sapiens	Kd	nM	5000.0
	19218809	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	IC50	nM	420.0	CHEMBL4355	Homo sapiens	IC50	nM	420.0
	19218810	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	=	IC50	nM	170.0	CHEMBL4355	Homo sapiens	IC50	nM	170.0
	19218811	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	IC50	nM	48.0	CHEMBL4355	Homo sapiens	IC50	nM	48.0
	19218812	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	IC50	nM	23.0	CHEMBL4355	Homo sapiens	IC50	nM	23.0
	19218813	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COc1cc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL309682	=	IC50	nM	350.0	CHEMBL4355	Homo sapiens	IC50	nM	350.0
	19218814	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL81073	=	IC50	nM	2.4	CHEMBL4355	Homo sapiens	IC50	nM	2.4
	19218815	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	C#Cc1cccc(Nc2ccnc3cc(OC)c(OC)cc23)c1		CHEMBL1092250	=	IC50	nM	500.0	CHEMBL4355	Homo sapiens	IC50	nM	500.0
	19218816	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL304929	=	IC50	nM	72.0	CHEMBL4355	Homo sapiens	IC50	nM	72.0
	19218817	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	C#Cc1cccc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c1		CHEMBL4440586	=	IC50	nM	31.0	CHEMBL4355	Homo sapiens	IC50	nM	31.0
	19218818	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COCCOc1cc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OCCOC		CHEMBL4468521	=	IC50	nM	2600.0	CHEMBL4355	Homo sapiens	IC50	nM	2600.0
	19218819	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	IC50	nM	910.0	CHEMBL4355	Homo sapiens	IC50	nM	910.0
	19218820	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	C#Cc1cccc(Nc2ccnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL1089203	=	IC50	nM	4200.0	CHEMBL4355	Homo sapiens	IC50	nM	4200.0
	19218821	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COc1cc2nccc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL98248	=	IC50	nM	510.0	CHEMBL4355	Homo sapiens	IC50	nM	510.0
	19218822	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	IC50	nM	260.0	CHEMBL4355	Homo sapiens	IC50	nM	260.0
	19218823	CHEMBL4394509	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells measured after 2 hrs by nanoBRET assay	B	COc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1OC		CHEMBL111038	=	IC50	nM	130.0	CHEMBL4355	Homo sapiens	IC50	nM	130.0
	19218824	CHEMBL4394510	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells at 5 uM measured after 2 hrs by nanoBRET assay relative to control	B	COc1cc(Nc2ncnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4446630	=	Inhibition	%	60.0	CHEMBL4355	Homo sapiens	INH	%	60.0
	19218825	CHEMBL4394510	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells at 5 uM measured after 2 hrs by nanoBRET assay relative to control	B	COc1cc2nccc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OC		CHEMBL4447797	=	Inhibition	%	22.0	CHEMBL4355	Homo sapiens	INH	%	22.0
	19218826	CHEMBL4394510	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells at 5 uM measured after 2 hrs by nanoBRET assay relative to control	B	COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OC		CHEMBL4467033	=	Inhibition	%	12.0	CHEMBL4355	Homo sapiens	INH	%	12.0
	19218827	CHEMBL4394510	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells at 5 uM measured after 2 hrs by nanoBRET assay relative to control	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Inhibition	%	0.0	CHEMBL4355	Homo sapiens	INH	%	0.0
	19218828	CHEMBL4394510	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells at 5 uM measured after 2 hrs by nanoBRET assay relative to control	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO		CHEMBL4514780	=	Inhibition	%	0.0	CHEMBL4355	Homo sapiens	INH	%	0.0
	19218829	CHEMBL4394510	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells at 5 uM measured after 2 hrs by nanoBRET assay relative to control	B	COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4462395	=	Inhibition	%	7.0	CHEMBL4355	Homo sapiens	INH	%	7.0
	19218830	CHEMBL4394510	Inhibition of tracer 5 binding to human N-terminal nano luciferase-fused GAK expressed in HEK293 cells at 5 uM measured after 2 hrs by nanoBRET assay relative to control	B	COc1cc(Nc2cc(C)nc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4518437	=	Inhibition	%	0.0	CHEMBL4355	Homo sapiens	INH	%	0.0
Active	19218911	CHEMBL4394528	Binding affinity to GAK in human SUM159 cell lysates by multiplexed inhibitor bead profiling-based LC-MS/MS analysis	B	C#Cc1cccc(Nc2ccnc3cc(OC)c(OC)cc23)c1		CHEMBL1092250		Activity			CHEMBL4355	Homo sapiens	Activity		
Active	19218912	CHEMBL4394528	Binding affinity to GAK in human SUM159 cell lysates by multiplexed inhibitor bead profiling-based LC-MS/MS analysis	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL304929		Activity			CHEMBL4355	Homo sapiens	Activity		
Active	19218913	CHEMBL4394528	Binding affinity to GAK in human SUM159 cell lysates by multiplexed inhibitor bead profiling-based LC-MS/MS analysis	B	COc1cc2nccc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL98248		Activity			CHEMBL4355	Homo sapiens	Activity		
	19218934	CHEMBL4394538	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Activity	%	50.0	CHEMBL4355	Homo sapiens	Activity	%	50.0
	19251842	CHEMBL4401826	Inhibition of recombinant human GST-tagged GAK (1 to 396 residues) expressed in insect cell expression system at 1 uM by kinomescan assay relative to control	B	O=C(CN1CCOCC1)N[C@H]1CC[C@H](Nc2cc(Cl)nn3c(-c4ccc5[nH]ncc5c4)cnc23)CC1		CHEMBL4565193	>	Inhibition	%	90.0	CHEMBL4355	Homo sapiens	INH	%	90.0
	19408376	CHEMBL4427044	Inhibition of human GAK expressed in bacterial system assessed as remaining enzyme activity at 1000 nM relative to untreated control	B	C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL4293051	<	Activity	%	1.0	CHEMBL4355	Homo sapiens	Activity	%	1.0
	19485723	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(Cl)cc23)cc(OC)c1OC		CHEMBL4556662	=	Kd	nM	6.7	CHEMBL4355	Homo sapiens	Kd	nM	6.7
	19485724	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	Kd	nM	2.9	CHEMBL4355	Homo sapiens	Kd	nM	2.9
	19485728	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3cc(C#N)ccc23)cc(OC)c1OC		CHEMBL4575895	=	Kd	nM	9.7	CHEMBL4355	Homo sapiens	Kd	nM	9.7
	19485732	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Kd	nM	1.9	CHEMBL4355	Homo sapiens	Kd	nM	1.9
	19485733	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1ccc2c(Nc3cc(OC)c(OC)c(OC)c3)ccnc2c1		CHEMBL4586530	=	Kd	nM	17.0	CHEMBL4355	Homo sapiens	Kd	nM	17.0
	19485738	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(C(C)(C)C)cc23)cc(OC)c1OC		CHEMBL530635	=	Kd	nM	25.0	CHEMBL4355	Homo sapiens	Kd	nM	25.0
	19485739	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	=	Kd	nM	31.0	CHEMBL4355	Homo sapiens	Kd	nM	31.0
	19485741	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(C#N)cc23)cc(OC)c1OC		CHEMBL4585158	=	Kd	nM	3.9	CHEMBL4355	Homo sapiens	Kd	nM	3.9
	19485742	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccccc23)cc(OC)c1OC		CHEMBL4586588	=	Kd	nM	59.0	CHEMBL4355	Homo sapiens	Kd	nM	59.0
	19485758	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(I)cc23)cc(OC)c1OC		CHEMBL4517424	=	Kd	nM	7.9	CHEMBL4355	Homo sapiens	Kd	nM	7.9
	19485759	CHEMBL4481498	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1ccc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2c1		CHEMBL4592501	=	Kd	nM	21.0	CHEMBL4355	Homo sapiens	Kd	nM	21.0
	19485768	CHEMBL4481505	Binding affinity to GAK (unknown origin) assessed as change in melting temperature by DSF assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Delta Tm	degrees C	7.7	CHEMBL4355	Homo sapiens	deltaTm	degrees C	7.7
	19485769	CHEMBL4481505	Binding affinity to GAK (unknown origin) assessed as change in melting temperature by DSF assay	B	COc1cc(Nc2cc(C)nc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4518437	=	Delta Tm	degrees C	-0.52	CHEMBL4355	Homo sapiens	deltaTm	degrees C	-0.52
	19485770	CHEMBL4481505	Binding affinity to GAK (unknown origin) assessed as change in melting temperature by DSF assay	B	COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4462395	=	Delta Tm	degrees C	-0.3	CHEMBL4355	Homo sapiens	deltaTm	degrees C	-0.3
	19485771	CHEMBL4481506	Binding affinity to C-terminal AVI-tagged GAK (unknown origin) (12 to 347 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Ki	nM	3.1	CHEMBL4355	Homo sapiens	Ki	uM	0.0031
	19485772	CHEMBL4481506	Binding affinity to C-terminal AVI-tagged GAK (unknown origin) (12 to 347 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	COc1cc(Nc2cc(C)nc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4518437	=	Ki	nM	19000.0	CHEMBL4355	Homo sapiens	Ki	uM	19.0
	19485773	CHEMBL4481506	Binding affinity to C-terminal AVI-tagged GAK (unknown origin) (12 to 347 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4462395	=	Ki	nM	2500.0	CHEMBL4355	Homo sapiens	Ki	uM	2.5
	19485774	CHEMBL4481506	Binding affinity to C-terminal AVI-tagged GAK (unknown origin) (12 to 347 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	Clc1cc2cc(c1)-c1cnn3ccc(nc13)NCCOCCO2		CHEMBL4531690	=	Ki	nM	3.8	CHEMBL4355	Homo sapiens	Ki	uM	0.0038
	19485775	CHEMBL4481506	Binding affinity to C-terminal AVI-tagged GAK (unknown origin) (12 to 347 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	Ki	nM	220.0	CHEMBL4355	Homo sapiens	Ki	uM	0.22
	19485776	CHEMBL4481506	Binding affinity to C-terminal AVI-tagged GAK (unknown origin) (12 to 347 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	Cc1[nH]nc(Nc2ncnc3cc(OCCO)c(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4535001	=	Ki	nM	49.0	CHEMBL4355	Homo sapiens	Ki	uM	0.049
	19485777	CHEMBL4481506	Binding affinity to C-terminal AVI-tagged GAK (unknown origin) (12 to 347 residues) expressed in Escherichia coli after 1.5 hrs by TR-FRET assay	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO		CHEMBL4514780	=	Ki	nM	8200.0	CHEMBL4355	Homo sapiens	Ki	uM	8.2
	19485787	CHEMBL4481510	Displacement of fluorescent tracer from N-terminus of human GAK expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	IC50	nM	120.0	CHEMBL4355	Homo sapiens	IC50	nM	120.0
	19485788	CHEMBL4481510	Displacement of fluorescent tracer from N-terminus of human GAK expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	Clc1cc2cc(c1)-c1cnn3ccc(nc13)NCCOCCO2		CHEMBL4531690	=	IC50	nM	0.06	CHEMBL4355	Homo sapiens	IC50	nM	0.06
Not Determined	19485789	CHEMBL4481510	Displacement of fluorescent tracer from N-terminus of human GAK expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499		IC50			CHEMBL4355	Homo sapiens	IC50		
Not Determined	19485790	CHEMBL4481510	Displacement of fluorescent tracer from N-terminus of human GAK expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	Cc1[nH]nc(Nc2ncnc3cc(OCCO)c(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4535001		IC50			CHEMBL4355	Homo sapiens	IC50		
	19485791	CHEMBL4481510	Displacement of fluorescent tracer from N-terminus of human GAK expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO		CHEMBL4514780	>	IC50	nM	10.0	CHEMBL4355	Homo sapiens	IC50	nM	10.0
Active	19485814	CHEMBL4481520	Inhibition of GAK in human 22Rv1 cells assessed as increase in histone H3 phosphorylation at Ser10 at 10 uM by Western blot analysis	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342		Inhibition	%		CHEMBL4355	Homo sapiens	INH		
	19485815	CHEMBL4481521	Binding affinity to GAK (unknown origin) by ITC assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Kd	nM	4.5	CHEMBL4355	Homo sapiens	Kd	nM	4.5
	19485816	CHEMBL4481522	Binding affinity to GAK (unknown origin)	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	13.0	CHEMBL4355	Homo sapiens	Kd	nM	13.0
	19485817	CHEMBL4481522	Binding affinity to GAK (unknown origin)	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3.1	CHEMBL4355	Homo sapiens	Kd	nM	3.1
	19485818	CHEMBL4481522	Binding affinity to GAK (unknown origin)	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	Kd	nM	8.9	CHEMBL4355	Homo sapiens	Kd	nM	8.9
	19485819	CHEMBL4481522	Binding affinity to GAK (unknown origin)	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	=	Kd	nM	31.0	CHEMBL4355	Homo sapiens	Kd	nM	31.0
	19485820	CHEMBL4481523	Binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli at 1 uM incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	>	Activity	%	50.0	CHEMBL4355	Homo sapiens	Activity	%	50.0
	19485823	CHEMBL4481526	Ratio of IC50 for displacement of fluorescent tracer from N-terminus of human GAK expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay to Kd for binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Ratio		63.0	CHEMBL4355	Homo sapiens	Ratio		63.0
Not Active	19485824	CHEMBL4481527	Displacement of fluorescent tracer from N-terminus of human GAK expressed in HEK293T cells up to 5 uM after 2 hrs by NanoBRET target engagement assay	B	COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4462395		Activity			CHEMBL4355	Homo sapiens	Activity		
	20598220	CHEMBL4602944	Inhibition of human GAK	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	IC50	nM	1000.0	CHEMBL4355	Homo sapiens	IC50	uM	1.0
	20629192	CHEMBL4610425	Binding affinity to GAK (unknown origin)	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3.1	CHEMBL4355	Homo sapiens	Kd	nM	3.1
	20629193	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1N		CHEMBL4172550	=	IC50	nM	39.4	CHEMBL4355	Homo sapiens	IC50	uM	0.0394
	20629194	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	C[C@H]1CN(c2snc3cc(-c4ccccc4)cnc23)C[C@@H](C)O1		CHEMBL4642436	=	IC50	nM	661.0	CHEMBL4355	Homo sapiens	IC50	uM	0.661
	20629195	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1ccc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)cc1OC		CHEMBL3425876	=	IC50	nM	136.0	CHEMBL4355	Homo sapiens	IC50	uM	0.136
	20629196	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)cc(OC)c1OC		CHEMBL4642620	=	IC50	nM	71.0	CHEMBL4355	Homo sapiens	IC50	uM	0.071
	20629197	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccn1		CHEMBL4636735	=	IC50	nM	545.0	CHEMBL4355	Homo sapiens	IC50	uM	0.545
	20629198	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1ccc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)cn1		CHEMBL4648166	>	IC50	nM	3330.0	CHEMBL4355	Homo sapiens	IC50	uM	3.33
	20629199	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1C(=O)O		CHEMBL4645917	=	IC50	nM	42.0	CHEMBL4355	Homo sapiens	IC50	uM	0.042
	20629200	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	C[C@H]1CN(c2snc3cc(/C=C/c4ccccc4)cnc23)C[C@@H](C)O1		CHEMBL4638607	>	IC50	nM	3330.0	CHEMBL4355	Homo sapiens	IC50	uM	3.33
	20629201	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	C[C@H]1CN(c2snc3cc(Nc4ccccc4)cnc23)C[C@@H](C)O1		CHEMBL4636582	=	IC50	nM	1630.0	CHEMBL4355	Homo sapiens	IC50	uM	1.63
	20629202	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1ccc(Nc2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)cc1OC		CHEMBL4639109	=	IC50	nM	1290.0	CHEMBL4355	Homo sapiens	IC50	uM	1.29
	20629203	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(Nc2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)cc(OC)c1OC		CHEMBL4634338	=	IC50	nM	458.0	CHEMBL4355	Homo sapiens	IC50	uM	0.458
	20629204	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	C[C@H]1CN(c2snc3cc(C#Cc4ccccc4)cnc23)C[C@@H](C)O1		CHEMBL4642223	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	uM	10.0
	20629205	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1C(N)=O		CHEMBL4646895	=	IC50	nM	22.0	CHEMBL4355	Homo sapiens	IC50	uM	0.022
	20629206	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1C(=O)NC1CC1		CHEMBL4632372	=	IC50	nM	118.0	CHEMBL4355	Homo sapiens	IC50	uM	0.118
	20629207	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1C(=O)N1CCCC1		CHEMBL4643096	=	IC50	nM	83.0	CHEMBL4355	Homo sapiens	IC50	uM	0.083
	20629208	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1C(=O)N1CCOCC1		CHEMBL4632903	=	IC50	nM	101.0	CHEMBL4355	Homo sapiens	IC50	uM	0.101
	20629209	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1C(=O)Nc1ccccc1		CHEMBL4644472	>	IC50	nM	370.0	CHEMBL4355	Homo sapiens	IC50	uM	0.37
	20629210	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1C(=O)NCc1ccccc1		CHEMBL4636314	=	IC50	nM	73.0	CHEMBL4355	Homo sapiens	IC50	uM	0.073
	20629211	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1NC=O		CHEMBL4638602	=	IC50	nM	113.0	CHEMBL4355	Homo sapiens	IC50	uM	0.113
	20629212	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1NC(C)=O		CHEMBL4640730	=	IC50	nM	132.0	CHEMBL4355	Homo sapiens	IC50	uM	0.132
	20629213	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1NC(=O)C1CC1		CHEMBL4640641	=	IC50	nM	173.0	CHEMBL4355	Homo sapiens	IC50	uM	0.173
	20629214	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2cnc3c(N4C[C@H](C)O[C@H](C)C4)snc3c2)ccc1NC(=O)c1ccccc1		CHEMBL4635431	=	IC50	nM	370.0	CHEMBL4355	Homo sapiens	IC50	uM	0.37
	20629215	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	C[C@H]1CN(c2snc3ccc(-c4ccccc4)nc23)C[C@@H](C)O1		CHEMBL4648554	=	IC50	nM	364.0	CHEMBL4355	Homo sapiens	IC50	uM	0.364
	20629216	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	C[C@H]1CN(c2snc3ccc(-c4ccc(C(F)(F)F)cc4)nc23)C[C@@H](C)O1		CHEMBL4648514	>	IC50	nM	370.0	CHEMBL4355	Homo sapiens	IC50	uM	0.37
	20629217	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	C[C@H]1CN(c2snc3ccc(-c4ccc(F)cc4)nc23)C[C@@H](C)O1		CHEMBL4639991	=	IC50	nM	110.0	CHEMBL4355	Homo sapiens	IC50	uM	0.11
	20629218	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	C[C@H]1CN(c2snc3ccc(-c4cccc(Cl)c4)nc23)C[C@@H](C)O1		CHEMBL4638387	=	IC50	nM	262.0	CHEMBL4355	Homo sapiens	IC50	uM	0.262
	20629219	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	Cc1ccc(-c2ccc3nsc(N4C[C@H](C)O[C@H](C)C4)c3n2)cc1		CHEMBL4648802	=	IC50	nM	214.0	CHEMBL4355	Homo sapiens	IC50	uM	0.214
	20629220	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cccc(-c2ccc3nsc(N4C[C@H](C)O[C@H](C)C4)c3n2)c1		CHEMBL4641825	=	IC50	nM	99.0	CHEMBL4355	Homo sapiens	IC50	uM	0.099
	20629221	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1ccc(-c2ccc3nsc(N4C[C@H](C)O[C@H](C)C4)c3n2)cc1OC		CHEMBL4642467	=	IC50	nM	24.0	CHEMBL4355	Homo sapiens	IC50	uM	0.024
	20629222	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(-c2ccc3nsc(N4C[C@H](C)O[C@H](C)C4)c3n2)cc(OC)c1OC		CHEMBL4637058	=	IC50	nM	422.0	CHEMBL4355	Homo sapiens	IC50	uM	0.422
	20629223	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cccc(-c2ccc3nsc(N4CCOCC4)c3n2)c1		CHEMBL4635935	=	IC50	nM	136.0	CHEMBL4355	Homo sapiens	IC50	uM	0.136
	20629224	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1ccc(-c2ccc3nsc(N4CCOCC4)c3n2)cc1OC		CHEMBL4633404	=	IC50	nM	124.0	CHEMBL4355	Homo sapiens	IC50	uM	0.124
	20629225	CHEMBL4610426	Inhibition of tracer 222 binding to recombinant human GST-tagged GAK (1 to 329 residues) expressed in insect cells incubated for 1 hr by Lanthascreen assay	B	COc1cc(OC)cc(-c2ccc3nsc(N4CCOCC4)c3n2)c1		CHEMBL4642058	=	IC50	nM	126.0	CHEMBL4355	Homo sapiens	IC50	uM	0.126
	20639579	CHEMBL4612729	Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1		CHEMBL4647810	=	Kd	nM	580.0	CHEMBL4355	Homo sapiens	Kd	nM	580.0
	22393819	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3ccccc23)cc(OC)c1OC		CHEMBL4586588	=	Kd	nM	170.0	CHEMBL4355	Homo sapiens	Kd	nM	170.0
	22393820	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3ccc(F)cc23)cc(OC)c1OC		CHEMBL4744568	=	Kd	nM	58.0	CHEMBL4355	Homo sapiens	Kd	nM	58.0
	22393821	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3ccc(Cl)cc23)cc(OC)c1OC		CHEMBL4556662	=	Kd	nM	6.3	CHEMBL4355	Homo sapiens	Kd	nM	6.3
	22393822	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Kd	nM	4.1	CHEMBL4355	Homo sapiens	Kd	nM	4.1
	22393823	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3ccc(I)cc23)cc(OC)c1OC		CHEMBL4517424	=	Kd	nM	8.6	CHEMBL4355	Homo sapiens	Kd	nM	8.6
	22393824	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3cc(F)ccc23)cc(OC)c1OC		CHEMBL4752943	=	Kd	nM	76.0	CHEMBL4355	Homo sapiens	Kd	nM	76.0
	22393825	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3cc(Cl)ccc23)cc(OC)c1OC		CHEMBL3925728	=	Kd	nM	13.0	CHEMBL4355	Homo sapiens	Kd	nM	13.0
	22393826	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3cc(Br)ccc23)cc(OC)c1OC		CHEMBL4782290	=	Kd	nM	8.6	CHEMBL4355	Homo sapiens	Kd	nM	8.6
	22393827	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3cc(I)ccc23)cc(OC)c1OC		CHEMBL4740155	=	Kd	nM	7.6	CHEMBL4355	Homo sapiens	Kd	nM	7.6
	22393828	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3ccc(C(C)(C)C)cc23)cc(OC)c1OC		CHEMBL530635	=	Kd	nM	34.0	CHEMBL4355	Homo sapiens	Kd	nM	34.0
	22393829	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3ccc(C#N)cc23)cc(OC)c1OC		CHEMBL4585158	=	Kd	nM	4.9	CHEMBL4355	Homo sapiens	Kd	nM	4.9
	22393830	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3ccc(S(C)(=O)=O)cc23)cc(OC)c1OC		CHEMBL4746235	=	Kd	nM	450.0	CHEMBL4355	Homo sapiens	Kd	nM	450.0
	22393831	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1ccc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2c1		CHEMBL4592501	=	Kd	nM	48.0	CHEMBL4355	Homo sapiens	Kd	nM	48.0
	22393832	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	Kd	nM	11.0	CHEMBL4355	Homo sapiens	Kd	nM	11.0
	22393833	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1ccc2c(Nc3cc(OC)c(OC)c(OC)c3)ccnc2c1		CHEMBL4586530	=	Kd	nM	35.0	CHEMBL4355	Homo sapiens	Kd	nM	35.0
	22393834	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3cc(C(F)(F)F)ccc23)cc(OC)c1OC		CHEMBL4746133	=	Kd	nM	23.0	CHEMBL4355	Homo sapiens	Kd	nM	23.0
	22393835	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3cc(C#N)ccc23)cc(OC)c1OC		CHEMBL4575895	=	Kd	nM	43.0	CHEMBL4355	Homo sapiens	Kd	nM	43.0
	22393836	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ncnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4446630	=	Kd	nM	130.0	CHEMBL4355	Homo sapiens	Kd	nM	130.0
	22393837	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cccc(Nc2ccnc3ccc(C(F)(F)F)cc23)c1		CHEMBL4781252	=	Kd	nM	4.9	CHEMBL4355	Homo sapiens	Kd	nM	4.9
	22393838	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4462395	=	Kd	nM	9900.0	CHEMBL4355	Homo sapiens	Kd	nM	9900.0
	22393839	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	=	Kd	nM	10.0	CHEMBL4355	Homo sapiens	Kd	nM	10.0
	22393840	CHEMBL4667704	Binding affinity to human wild type partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by KinomeScan method	B	COc1cc(Nc2cc(C)nc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4518437	>	Kd	nM	30000.0	CHEMBL4355	Homo sapiens	Kd	nM	30000.0
	22393869	CHEMBL4667719	Inhibition of GAK (unknown origin) by in-cell pulse based assay	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	=	IC50	nM	210.0	CHEMBL4355	Homo sapiens	IC50	nM	210.0
	22393870	CHEMBL4667719	Inhibition of GAK (unknown origin) by in-cell pulse based assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	IC50	nM	200.0	CHEMBL4355	Homo sapiens	IC50	nM	200.0
	22393871	CHEMBL4667719	Inhibition of GAK (unknown origin) by in-cell pulse based assay	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	IC50	nM	45.0	CHEMBL4355	Homo sapiens	IC50	nM	45.0
	22393872	CHEMBL4667719	Inhibition of GAK (unknown origin) by in-cell pulse based assay	B	COc1cc(Nc2ncnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4446630	=	IC50	nM	6700.0	CHEMBL4355	Homo sapiens	IC50	nM	6700.0
	22393873	CHEMBL4667719	Inhibition of GAK (unknown origin) by in-cell pulse based assay	B	COc1cccc(Nc2ccnc3ccc(C(F)(F)F)cc23)c1		CHEMBL4781252	=	IC50	nM	380.0	CHEMBL4355	Homo sapiens	IC50	nM	380.0
	22393874	CHEMBL4667719	Inhibition of GAK (unknown origin) by in-cell pulse based assay	B	COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4462395	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	22393875	CHEMBL4667719	Inhibition of GAK (unknown origin) by in-cell pulse based assay	B	COc1cc(Nc2cc(C)nc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4518437	>	IC50	nM	10000.0	CHEMBL4355	Homo sapiens	IC50	nM	10000.0
	22393876	CHEMBL4667720	Binding affinity to T7-tagged GAK (unknown origin) expressed in Escherichia coli BL21 incubated for 1 hr	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1.3	CHEMBL4355	Homo sapiens	Kd	nM	1.3
	22393877	CHEMBL4667720	Binding affinity to T7-tagged GAK (unknown origin) expressed in Escherichia coli BL21 incubated for 1 hr	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3.1	CHEMBL4355	Homo sapiens	Kd	nM	3.1
	22393878	CHEMBL4667720	Binding affinity to T7-tagged GAK (unknown origin) expressed in Escherichia coli BL21 incubated for 1 hr	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	13.0	CHEMBL4355	Homo sapiens	Kd	nM	13.0
	22393882	CHEMBL4667723	Binding affinity to GAK (unknown origin)	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	=	Kd	nM	31.0	CHEMBL4355	Homo sapiens	Kd	nM	31.0
	22393883	CHEMBL4667723	Binding affinity to GAK (unknown origin)	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Kd	nM	29.0	CHEMBL4355	Homo sapiens	Kd	nM	29.0
	22393884	CHEMBL4667723	Binding affinity to GAK (unknown origin)	B	COc1cc(-c2cnc3cc(-c4ccncc4)ccc3c2)cc(OC)c1OC		CHEMBL4797973	=	Ki	nM	1.5	CHEMBL4355	Homo sapiens	Ki	nM	1.5
	22775425	CHEMBL4705534	Inhibition of human GAK at 10 nM relative to control	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	Inhibition	%	79.0	CHEMBL4355	Homo sapiens	INH	%	79.0
	22775426	CHEMBL4705535	Inhibition of human GAK	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	<	IC50	nM	10.0	CHEMBL4355	Homo sapiens	IC50	nM	10.0
	22775427	CHEMBL4705536	Inhibition of human GAK at 100 nM relative to control	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	=	Inhibition	%	59.0	CHEMBL4355	Homo sapiens	INH	%	59.0
	22886523	CHEMBL4728253	Binding affinity to GAK (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	6.0	CHEMBL4355	Homo sapiens	deltaTm	degrees C	6.0
	22921969	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)ccc1N		CHEMBL3425867	=	IC50	nM	51.0	CHEMBL4355	Homo sapiens	IC50	uM	0.051
	22921970	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	11.0	CHEMBL4355	Homo sapiens	IC50	uM	0.011000000000000001
	22921971	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CCC(=O)Nc1cccc(-c2snc3cc(-c4ccc(N)c(OC)c4)cnc23)c1		CHEMBL4764705	=	IC50	nM	7.7	CHEMBL4355	Homo sapiens	IC50	uM	0.0077
	22921972	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(-c4cccc(NC(=O)C(C)C)c4)snc3c2)ccc1N		CHEMBL4762694	=	IC50	nM	3.8	CHEMBL4355	Homo sapiens	IC50	uM	0.0038
	22921973	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(-c4cccc(NC(=O)C5CC5)c4)snc3c2)ccc1N		CHEMBL4794323	=	IC50	nM	8.8	CHEMBL4355	Homo sapiens	IC50	uM	0.0088
	22921974	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(-c4cccc(NC(=O)C5CCCC5)c4)snc3c2)ccc1N		CHEMBL4779229	=	IC50	nM	17.0	CHEMBL4355	Homo sapiens	IC50	uM	0.017
	22921975	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(-c4cccc(NC(=O)N5CCCC5)c4)snc3c2)ccc1N		CHEMBL4740761	=	IC50	nM	2.2	CHEMBL4355	Homo sapiens	IC50	uM	0.0022
	22921976	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(-c4cccc(NC(=O)N5CCOCC5)c4)snc3c2)ccc1N		CHEMBL4778276	=	IC50	nM	3.2	CHEMBL4355	Homo sapiens	IC50	uM	0.0032
	22921977	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CCC(=O)Nc1ccc(-c2snc3cc(-c4ccc(N)c(OC)c4)cnc23)cc1		CHEMBL4782593	>	IC50	nM	1100.0	CHEMBL4355	Homo sapiens	IC50	uM	1.1
	22921978	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CCC(=O)NC1CCCN(c2snc3cc(-c4ccc(N)c(OC)c4)cnc23)C1		CHEMBL4798132	=	IC50	nM	900.0	CHEMBL4355	Homo sapiens	IC50	uM	0.9
	22921979	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CCC(=O)NCC1CCCN(c2snc3cc(-c4ccc(N)c(OC)c4)cnc23)C1		CHEMBL4782363	=	IC50	nM	74.0	CHEMBL4355	Homo sapiens	IC50	uM	0.07400000000000001
	22921980	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CCC(=O)NCCC1CCCN(c2snc3cc(-c4ccc(N)c(OC)c4)cnc23)C1		CHEMBL4777592	=	IC50	nM	190.0	CHEMBL4355	Homo sapiens	IC50	uM	0.19
	22921981	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CCC(=O)NCC1CCN(c2snc3cc(-c4ccc(N)c(OC)c4)cnc23)CC1		CHEMBL4759566	=	IC50	nM	1800.0	CHEMBL4355	Homo sapiens	IC50	uM	1.8
	22921982	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCCC(CNC(=O)CC(C)C)C4)snc3c2)ccc1N		CHEMBL4760106	=	IC50	nM	69.0	CHEMBL4355	Homo sapiens	IC50	uM	0.069
	22921983	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCCC(CNC(=O)C5CC5)C4)snc3c2)ccc1N		CHEMBL4800032	=	IC50	nM	14.0	CHEMBL4355	Homo sapiens	IC50	uM	0.013999999999999999
	22921984	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCCC(CNC(=O)C5CCCC5)C4)snc3c2)ccc1N		CHEMBL4755134	=	IC50	nM	39.0	CHEMBL4355	Homo sapiens	IC50	uM	0.039
	22921985	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCCC(CNC(=O)c5ccccc5)C4)snc3c2)ccc1N		CHEMBL4752286	=	IC50	nM	35.0	CHEMBL4355	Homo sapiens	IC50	uM	0.035
	22921986	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCCC(CNC(=O)N5CCCC5)C4)snc3c2)ccc1N		CHEMBL4784439	=	IC50	nM	37.0	CHEMBL4355	Homo sapiens	IC50	uM	0.037000000000000005
	22921987	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCCC(CNC(=O)N5CCOCC5)C4)snc3c2)ccc1N		CHEMBL4799769	=	IC50	nM	85.0	CHEMBL4355	Homo sapiens	IC50	uM	0.085
	22921988	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCCC(CNS(=O)(=O)C5CC5)C4)snc3c2)ccc1N		CHEMBL4753946	=	IC50	nM	78.0	CHEMBL4355	Homo sapiens	IC50	uM	0.078
	22921989	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCCC(CNC(=O)NC5CC5)C4)snc3c2)ccc1N		CHEMBL4790097	=	IC50	nM	62.0	CHEMBL4355	Homo sapiens	IC50	uM	0.062
	22921990	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCC[C@@H](CNC(=O)C5CC5)C4)snc3c2)ccc1N		CHEMBL4747444	=	IC50	nM	360.0	CHEMBL4355	Homo sapiens	IC50	uM	0.36
	22921991	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	COc1cc(-c2cnc3c(N4CCC[C@H](CNC(=O)C5CC5)C4)snc3c2)ccc1N		CHEMBL4745028	=	IC50	nM	13.0	CHEMBL4355	Homo sapiens	IC50	uM	0.013000000000000001
	22921992	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	C=CC(=O)Nc1cccc(-c2snc3cc(-c4ccc(N)c(OC)c4)cnc23)c1		CHEMBL4745919	=	IC50	nM	12.0	CHEMBL4355	Homo sapiens	IC50	uM	0.012
	22921993	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	C=CC(=O)NCC1CCCN(c2snc3cc(-c4ccc(N)c(OC)c4)cnc23)C1		CHEMBL4756485	=	IC50	nM	78.0	CHEMBL4355	Homo sapiens	IC50	uM	0.078
	22921994	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	C=CC(=O)NCC1CCN(c2snc3c(-c4ccc(OC)c(N)c4)ccnc23)CC1		CHEMBL4745993	=	IC50	nM	1700.0	CHEMBL4355	Homo sapiens	IC50	uM	1.7
	22921995	CHEMBL4736826	Inhibition of tracer 222 binding to GAK (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	C=CC(=O)Nc1ccc(-c2snc3cc(-c4ccc(N)c(OC)c4)cnc23)cc1		CHEMBL4800155	=	IC50	nM	500.0	CHEMBL4355	Homo sapiens	IC50	uM	0.5
	22922024	CHEMBL4736831	Inhibition of NanoBRET tracer 5 binding to NL-fused GAK (unknown origin) expressed in HEK293 cells measured after 2 hrs by NanoBRET assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	IC50	nM	48.0	CHEMBL4355	Homo sapiens	IC50	nM	48.0
	22922031	CHEMBL4736838	Binding affinity to GAK (unknown origin)	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3.1	CHEMBL4355	Homo sapiens	Kd	nM	3.1
	22926347	CHEMBL4737626	Inhibition of human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by kinome scan method relative to control	B	COc1ncc(-c2ccc3nccc(/C(C)=C/C(=O)N4CCN(C)CC4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL4739883	=	Activity	%	22.0	CHEMBL4355	Homo sapiens	Activity	%	22.0
	23122285	CHEMBL4804721	Inhibition of GAK in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	51100.0	CHEMBL4355	Homo sapiens	IC50	uM	51.1
	23122286	CHEMBL4804721	Inhibition of GAK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	50400.0	CHEMBL4355	Homo sapiens	IC50	uM	50.4
	23122287	CHEMBL4804721	Inhibition of GAK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	7700.0	CHEMBL4355	Homo sapiens	IC50	uM	7.7
	23122288	CHEMBL4804722	Inhibition of GAK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	23122289	CHEMBL4804722	Inhibition of GAK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	50.0	CHEMBL4355	Homo sapiens	INH	%	50.0
	23122290	CHEMBL4804722	Inhibition of GAK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL4355	Homo sapiens	INH	%	0.0
	23122592	CHEMBL4804943	Inhibition of human GAK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL4355	Homo sapiens	Activity	%	100.0
	23123287	CHEMBL4805531	Inhibition of human GAK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	92.0	CHEMBL4355	Homo sapiens	Activity	%	92.0
	23123608	CHEMBL4805852	Inhibition of DNA-tagged human GAK assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	98.0	CHEMBL4355	Homo sapiens	Activity	%	98.0
	23124664	CHEMBL4806548	Inhibition of human GAK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	88.0	CHEMBL4355	Homo sapiens	Activity	%	88.0
	23124665	CHEMBL4806548	Inhibition of human GAK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	94.0	CHEMBL4355	Homo sapiens	Activity	%	94.0
	23195927	CHEMBL4819742	Inhibition of GAK (unknown origin) direct filter-binding radiometric kinase activity assay relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)C4CCCCC4)CC3)c2n1		CHEMBL4875028	=	Inhibition	%	70.0	CHEMBL4355	Homo sapiens	INH	%	70.0
	23213417	CHEMBL4822951	Inhibition of human recombinant GAK by Lanthascreen assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	24.0	CHEMBL4355	Homo sapiens	INH	%	24.0
	23234011	CHEMBL4827590	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	<	Activity	%	10.0	CHEMBL4355	Homo sapiens	Activity	%	10.0
	23240825	CHEMBL4829150	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC(F)F)c1		CHEMBL4872886	=	Activity	%	21.0	CHEMBL4355	Homo sapiens	Activity	%	21.0
	23240839	CHEMBL4829164	Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC(F)F)c1		CHEMBL4872886	=	IC50	nM	1060.0	CHEMBL4355	Homo sapiens	IC50	uM	1.06
	23240914	CHEMBL4829239	Binding affinity to GAK (unknown origin)	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	120.0	CHEMBL4355	Homo sapiens	Kd	nM	120.0
	23312270	CHEMBL4844323	Inhibition of GAK (unknown origin) at 1 uM relative to control	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1ccc2c(n1)[C@](C)(O)CC2		CHEMBL4871803	=	Inhibition	%	75.0	CHEMBL4355	Homo sapiens	INH	%	75.0
Not Active	23317427	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	99.0	CHEMBL4355	Homo sapiens	% Control	%	99.0
Not Active	23317895	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	96.0	CHEMBL4355	Homo sapiens	% Control	%	96.0
Not Active	23318564	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	97.0	CHEMBL4355	Homo sapiens	% Control	%	97.0
Not Active	23319045	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	91.0	CHEMBL4355	Homo sapiens	% Control	%	91.0
Not Active	23319682	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23320157	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	95.8	CHEMBL4355	Homo sapiens	% Control	%	95.8
Not Active	23320835	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23321303	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	99.0	CHEMBL4355	Homo sapiens	% Control	%	99.0
Not Active	23321933	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	93.0	CHEMBL4355	Homo sapiens	% Control	%	93.0
Not Active	23322401	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	98.0	CHEMBL4355	Homo sapiens	% Control	%	98.0
Not Active	23323090	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23323558	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23324412	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23325047	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23325515	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	91.0	CHEMBL4355	Homo sapiens	% Control	%	91.0
Not Active	23326162	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	99.0	CHEMBL4355	Homo sapiens	% Control	%	99.0
Not Active	23326630	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	76.0	CHEMBL4355	Homo sapiens	% Control	%	76.0
Not Active	23327330	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	97.0	CHEMBL4355	Homo sapiens	% Control	%	97.0
Not Active	23327798	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	96.0	CHEMBL4355	Homo sapiens	% Control	%	96.0
Not Active	23328385	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	95.0	CHEMBL4355	Homo sapiens	% Control	%	95.0
Not Active	23328853	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	98.0	CHEMBL4355	Homo sapiens	% Control	%	98.0
Not Active	23329799	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23330267	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23331023	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23331491	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	97.0	CHEMBL4355	Homo sapiens	% Control	%	97.0
Not Active	23332078	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	83.3	CHEMBL4355	Homo sapiens	% Control	%	83.3
Not Active	23332544	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23333262	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	97.2	CHEMBL4355	Homo sapiens	% Control	%	97.2
Not Active	23333901	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	88.0	CHEMBL4355	Homo sapiens	% Control	%	88.0
Not Active	23334369	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	90.0	CHEMBL4355	Homo sapiens	% Control	%	90.0
Not Active	23335348	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23335816	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23336443	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	91.0	CHEMBL4355	Homo sapiens	% Control	%	91.0
Not Active	23336911	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23337992	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23338460	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23339072	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23339540	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	71.0	CHEMBL4355	Homo sapiens	% Control	%	71.0
Not Active	23340177	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	85.0	CHEMBL4355	Homo sapiens	% Control	%	85.0
Not Active	23340645	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23341302	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23341770	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	97.0	CHEMBL4355	Homo sapiens	% Control	%	97.0
Not Active	23342386	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23342854	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23343484	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	85.0	CHEMBL4355	Homo sapiens	% Control	%	85.0
Not Active	23343952	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	90.0	CHEMBL4355	Homo sapiens	% Control	%	90.0
Not Active	23344590	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23345163	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	95.0	CHEMBL4355	Homo sapiens	% Control	%	95.0
Not Active	23345631	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	90.0	CHEMBL4355	Homo sapiens	% Control	%	90.0
Not Active	23346208	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23346677	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23347282	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23347768	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23348347	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23348815	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23349402	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	89.0	CHEMBL4355	Homo sapiens	% Control	%	89.0
Not Active	23350020	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	88.0	CHEMBL4355	Homo sapiens	% Control	%	88.0
Not Active	23350488	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	92.0	CHEMBL4355	Homo sapiens	% Control	%	92.0
Not Active	23351093	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23351561	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	93.0	CHEMBL4355	Homo sapiens	% Control	%	93.0
Not Active	23352585	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	86.0	CHEMBL4355	Homo sapiens	% Control	%	86.0
Not Active	23353053	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	86.0	CHEMBL4355	Homo sapiens	% Control	%	86.0
Not Active	23353935	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23354403	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23355135	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23355603	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23356239	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23356707	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23357316	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	98.0	CHEMBL4355	Homo sapiens	% Control	%	98.0
Not Active	23357963	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23358431	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23359017	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	99.6	CHEMBL4355	Homo sapiens	% Control	%	99.6
Not Active	23359615	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23360083	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23360668	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	94.0	CHEMBL4355	Homo sapiens	% Control	%	94.0
Not Active	23361136	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23361709	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	83.0	CHEMBL4355	Homo sapiens	% Control	%	83.0
Not Active	23362245	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23362713	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	91.0	CHEMBL4355	Homo sapiens	% Control	%	91.0
Not Active	23364355	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	99.0	CHEMBL4355	Homo sapiens	% Control	%	99.0
Not Active	23364823	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23365562	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23366105	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23366695	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23367163	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23368041	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	94.0	CHEMBL4355	Homo sapiens	% Control	%	94.0
Not Active	23368509	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	89.0	CHEMBL4355	Homo sapiens	% Control	%	89.0
Not Active	23369108	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	95.0	CHEMBL4355	Homo sapiens	% Control	%	95.0
Not Active	23369576	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	82.0	CHEMBL4355	Homo sapiens	% Control	%	82.0
Not Active	23370544	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	82.0	CHEMBL4355	Homo sapiens	% Control	%	82.0
Not Active	23371012	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23371821	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	96.0	CHEMBL4355	Homo sapiens	% Control	%	96.0
Not Active	23372289	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	95.0	CHEMBL4355	Homo sapiens	% Control	%	95.0
	23372752	CHEMBL4884717	GAK(GAK1PGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4355	Homo sapiens	pIC50		6.0
	23373161	CHEMBL4885008	GAK(GAK1PGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4355	Homo sapiens	pIC50		6.0
	23373522	CHEMBL4885299	GAK(GAK1PGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4355	Homo sapiens	pIC50		6.0
Not Active	23375716	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23376184	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23376761	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	97.0	CHEMBL4355	Homo sapiens	% Control	%	97.0
Not Active	23377230	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23378089	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23378557	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23379724	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23380192	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23380886	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	88.0	CHEMBL4355	Homo sapiens	% Control	%	88.0
Not Active	23381534	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	92.0	CHEMBL4355	Homo sapiens	% Control	%	92.0
Not Active	23382002	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4355	Homo sapiens	% Control	%	100.0
Not Active	23382626	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	69.0	CHEMBL4355	Homo sapiens	% Control	%	69.0
Not Active	23383094	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	66.0	CHEMBL4355	Homo sapiens	% Control	%	66.0
Active	23383616	CHEMBL4887276	GAK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	7.0	CHEMBL4355	Homo sapiens	% Ctrl	%	7.0
Active	23383617	CHEMBL4887276	GAK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	6.0	CHEMBL4355	Homo sapiens	% Ctrl	%	6.0
Not Active	23383618	CHEMBL4887276	GAK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	99.0	CHEMBL4355	Homo sapiens	% Ctrl	%	99.0
Slightly Active	23384078	CHEMBL4887160	Dose response measurement (GAK)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		IC50	nM	188.0	CHEMBL4355	Homo sapiens	IC50	nM	188.0
Not Active	23384081	CHEMBL4887163	NanoBRET (SGC-FFM) (GAK)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12	Non standard unit for type	CHEMBL4522930		IC50	M	6.5	CHEMBL4355	Homo sapiens	IC50	M	6.5
Not Active	23385009	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	98.0	CHEMBL4355	Homo sapiens	% Control	%	98.0
Not Active	23385476	CHEMBL4879733	KinomeScan assay: inhibition of GAK	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	93.0	CHEMBL4355	Homo sapiens	% Control	%	93.0
